-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AS42XJ2ohx1+Jx/mGFA8OQvnoPkDsPfKP9Qn+LzMynfBPXHwQSWAPpyocfVlqnEY MBdiGLlxPlM763NxgI++ng== 0001122304-07-000049.txt : 20070426 0001122304-07-000049.hdr.sgml : 20070426 20070426063538 ACCESSION NUMBER: 0001122304-07-000049 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20070426 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070426 DATE AS OF CHANGE: 20070426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AETNA INC /PA/ CENTRAL INDEX KEY: 0001122304 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 232229683 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16095 FILM NUMBER: 07789151 BUSINESS ADDRESS: STREET 1: 151 FARMINGTON AVENUE CITY: HARTFORD STATE: CT ZIP: 06156 BUSINESS PHONE: 8602730123 MAIL ADDRESS: STREET 1: 151 FARMINGTON AVENUE CITY: HARTFORD STATE: CT ZIP: 06156 FORMER COMPANY: FORMER CONFORMED NAME: AETNA U S HEALTHCARE INC DATE OF NAME CHANGE: 20000822 8-K 1 form8-k.htm AETNA FORM 8-K MARCH 31, 2007 form8-k.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):
April 26, 2007
 

             
Aetna Inc.
(Exact name of registrant as specified in its charter)


Pennsylvania
1-16095
23-2229683
(State or other jurisdiction of
(Commission
(I.R.S. Employer
incorporation)
File Number)
Identification No.)

151 Farmington Avenue, Hartford, CT
06156
(Address of principal executive offices)
(Zip Code)



Registrant’s telephone number, including area code:
(860) 273-0123


Former name or former address, if changed since last report:
Not applicable


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
Section 2 – Financial Information

Item 2.02    Results of Operations and Financial Condition.

On April 26, 2007, Aetna Inc. issued a press release announcing results for the quarter ended March 31, 2007.  A copy of that press release is furnished herewith as Exhibit 99.1 and hereby incorporated in this Item 2.02 by reference.

The information in this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.


Section 9 – Financial Statements and Exhibits

Item 9.01    Financial Statements and Exhibits.

(d) Exhibits.

99.1  
Press release of Aetna Inc. dated April 26, 2007 announcing results for the quarter ended March 31, 2007.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AETNA INC.

 
Date:  April 26, 2007                                                             By:                        /s/ Ronald M. Olejniczak
             -----------------------------------
             Name: Ronald M. Olejniczak
             Title: Vice President and Controller
 
 
 
 



 
Exhibit
Number                          Description 

 
Exhibit 99.1                    Press release of Aetna Inc. dated April 26, 2007 announcing results for the quarter ended March 31, 2007.
 
 
 
 
 

EX-99.1 2 ex99-1.htm AETNA PRESS RELEASE MARCH 31, 2007 ex99-1.htm
Exhibit 99.1
 
 
 
151 Farmington Avenue
Hartford, Conn.  06156
Media Contact:
Fred Laberge
860-273-4788
labergear@aetna.com
 
   
Investor Contact:
David W. Entrekin
860-273-7830
entrekind@aetna.com

News Release _________________________________________________________

 
AETNA REPORTS FIRST-QUARTER 2007 RESULTS
  
First-quarter operating earnings were $0.81 per share, compared to the Thomson/First Call mean of $0.77, an increase of 27 percent over the prior-year quarter
  
First-quarter net income was $0.81 per share, a 19 percent increase over the prior-year quarter
  
First-quarter medical membership increased by 270,000 to 15.7 million
  
First-quarter Commercial Medical Benefit Ratio was 79.6 percent
  
Guidance: Full-year 2007 operating earnings projected to be $3.35 per share, an increase from our prior guidance of $3.30 per share

HARTFORD, Conn., April 26, 2007― Aetna (NYSE: AET) today announced first-quarter 2007 operating earnings of $0.81 per share, an increase of 27 percent compared to the prior-year quarter. The increase in operating earnings reflects revenue growth from quarter-over-quarter premium and fee rate increases and membership growth, as well as solid underwriting results and continued general and administrative expense efficiencies. Operating earnings exclude net realized capital gains (losses) and other items.(1)  First quarter 2007 net income was $0.81 per share, an increase of 19 percent over the prior-year quarter.

Aetna/2
                   
Quarterly Financial Results at a Glance        
 
                   
   
Three Months Ended March 31,
 
(Millions, except per common share)
 
2007
   
2006
   
Change
 
Total revenue
  $
6,700.0
    $
6,234.7
      7 %
Operating earnings(1)
   
435.4
     
380.3
      14 %
Net income
   
434.6
     
401.7
      8 %
                         
Per share results:
                       
Operating earnings(1)
   
0.81
     
0.64
      27 %
Net income
   
0.81
     
0.68
      19 %
                         
Weighted average common shares - diluted
   
536.4
     
593.1
         

“Our strong financial results in the first quarter demonstrate that our disciplined strategy of profitable growth is working,” said Ronald A. Williams, chairman and CEO. “Our customers and members clearly are responding to Aetna’s value proposition of providing high-quality products and services and superior medical management capabilities that help manage costs. Those factors, as well as the steps we have taken to diversify our revenue and earnings, led to a strong performance across all of our health care product lines: medical, dental, pharmacy and behavioral.

“I also would note the recent announcement of our partnership with AARP. In addition to being a tremendous market opportunity, this new initiative will allow Aetna to work with AARP to increase access to health care for millions of Americans aged 50-64, further enhancing Aetna’s leadership in providing affordable, high quality health care as well as enhanced prevention and wellness programs,” Williams said.

“Aetna’s continued growth in medical membership, revenue and earnings in the first quarter demonstrates our focus on delivering superior financial results,” said Joseph M. Zubretsky, executive vice president and chief financial officer. “Two items stand out: Our disciplined pricing and medical management initiatives led to a very positive Commercial Medical Benefit Ratio of 79.6 percent.  And our disciplined approach to managing administrative costs is reflected in the 110 basis-point decline quarter over quarter operating expense ratio, to 18 percent.(2)

“Looking forward to the remainder of 2007, we have confidence in our ability to perform at a high level, and therefore we are raising our annual operating earnings per share estimate to $3.35 for the year and $0.79 per share for the second quarter.”(3)


Aetna/3
 
Health Care business results
Health Care, which provides a full range of insured and self-insured medical, dental, pharmacy and behavioral health products and services, reported:
  
Operating earnings of $422.7 million for the first quarter of 2007, compared with $360.6 million for the first quarter of 2006. The increase in operating earnings reflects a 9 percent increase in revenue primarily from premium and fee rate increases and membership growth, as well as solid underwriting results and continued general and administrative expense efficiencies.
  
Net income of $420.4 million for the first quarter of 2007, compared with $364.3 million for the first quarter of 2006.
  
A Commercial Medical Benefit Ratio (“MBR”) (formerly referred to as the Commercial Risk MCR) of 79.6 percent for the first quarter of 2007, compared to 79.4 percent for the first quarter of 2006.
  
A Medicare MBR of 88.0 percent for the first quarter of 2007, compared to 87.3 percent for the first quarter of 2006.
  
A total MBR of 80.7 percent for the first quarter of 2007, compared to 80.1 percent for the first quarter of 2006. Total MBR combines the benefit ratios of the Commercial, Medicare and Medicaid products.
  
Total medical membership of 15.703 million at March 31, 2007, compared with 15.433 million at December 31, 2006, an increase of approximately 270,000. First quarter pharmacy membership increased by 281,000 to 10.496 million and dental membership increased by 183,000 to 13.655 million from December 31, 2006.
 
Total revenues for the first quarter of 2007 increased by 9 percent to $6.0 billion from $5.5 billion for the first quarter of 2006.

 
Group Insurance business results
Group Insurance, which includes group life, disability and long-term care products, reported:
·  
Operating earnings of $31.1 million for the first quarter of 2007, compared with $32.2 million for the first quarter of 2006, reflecting higher operating expenses in support of disability product growth.
·  
Net income of $31.3 million for the first quarter of 2007, compared with $28.2 million for the first quarter of 2006.


Aetna/4
 
 
·  
Total revenues for first quarter of 2007 were $544.4 million, compared with $535.2 million for the first quarter of 2006.

Large Case Pensions business results
Large Case Pensions, which manages a variety of discontinued and other retirement and savings products, primarily qualified pension plans, reported:
·  
Operating earnings of $9.1 million for the first quarter of 2007, compared with $9.3 million for the first quarter of 2006.
·  
Net income of $10.4 million for the first quarter of 2007, compared with $14.9 million for the first quarter of 2006.

Total company results
·  
Total Revenues.  Revenues increased 7 percent to $6.7 billion for the first quarter of 2007, compared with $6.2 billion for the first quarter of 2006. The growth in first-quarter revenue reflects premium and fee rate increases and a higher level of membership that resulted in an increase of 9 percent in premiums and 6 percent in fees and other revenue.
·  
Total Operating Expenses.  Operating expenses were $1.2 billion for the first quarter of 2007, $16 million higher than the first quarter of 2006, excluding the acquisition-related software write-off of $8.3 million pretax in the 2006 period.  Including the acquisition-related software write-off, operating expenses were $7 million higher than the first quarter of 2006.  Operating expenses, excluding the acquisition-related software  write-off, as a percentage of revenue improved to 18.0 percent for the first quarter of 2007 from 19.1 percent for the first quarter of 2006, reflecting continued expense efficiencies. Including net realized capital gains (losses) and the acquisition-related software write-off, these percentages were 18.0 percent for the first quarter of 2007 and 19.2 percent for the first quarter of 2006.
·  
Corporate Interest Expense, after tax, was $27.5 million for the first quarter of 2007, compared with $21.8 million for the first quarter of 2006.  The increase was due to higher average debt levels due to the company’s debt refinancing in June 2006.
·  
Net Income.  Aetna reported net income of $434.6 million for the first quarter of 2007, compared with $401.7 million for the first quarter of 2006.
·  
Operating Margin was 10.9 percent for the first quarter of 2007, compared with 10.3 percent for the first quarter of 2006, pre-tax.(4) The after-tax operating margin, which represents income from continuing operations divided by total revenue, was 6.5 percent for the first quarter of 2007, compared with 6.2 percent for the first quarter of 2006.
 

Aetna/5
 
A live audio webcast of the first-quarter results conference call will begin at 8:30 a.m. ET today.  The public may access the conference call through a live audio webcast available on Aetna’s Investor Information link on the Internet at www.aetna.com.  Financial, statistical and other information, including U.S. generally accepted accounting principles (“GAAP”) reconciliations, related to the conference call also will be available on Aetna’s Investor Information web site.

The conference call also can be accessed by dialing 800-819-9193, or 913-981-4911 for international callers.  The company suggests participants dial in approximately 10 minutes before the call.  Individuals who dial in will be asked to identify themselves and their affiliations.

A replay of the call may be accessed through Aetna’s Investor Information link on the Internet at www.aetna.com or by dialing 888-203-1112, or 719-457-0820 for international callers.  The replay access code is 3821463. Telephone replays will be available from 11:30 a.m. ET on April 26 until midnight ET on May 9.

Aetna is one of the nation’s leading diversified health care benefits companies, serving approximately 34.9 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life, long-term care and disability plans, and medical management capabilities. Our customers include employer groups, individuals, college students, part-time and hourly workers, health plans and government-sponsored plans. www.aetna.com


 

Aetna/6
             
             
             
Consolidated Statements of Income     
 
($ in Millions)     
 
             
             
   
Three Months Ended   
 
   
March 31,
   
March 31,
 
   
2007
   
2006
 
             
Revenue:
           
Health care premiums
  $
5,178.5
    $
4,726.1
 
Other premiums
   
495.4
     
502.1
 
Fees and other revenue
   
732.8
     
690.9
 
Net investment income
   
294.5
     
298.0
 
Net realized capital (losses) gains
    (1.2 )    
17.6
 
             Total Revenue     6,700.0        6,234.7   
                 
Benefits and expenses:
               
Health care costs
   
4,177.1
     
3,786.2
 
Current and future benefits
   
590.4
     
600.7
 
Operating expenses:
               
Selling expenses
   
269.8
     
243.5
 
               General and administrative expenses (5)
   
934.7
     
953.6
 
           Total operating expenses
   
1,204.5
     
1,197.1
 
Interest expense
   
42.3
     
33.5
 
Amortization of other acquired intangible assets
   
21.8
     
19.9
 
Total benefits and expenses
   
6,036.1
     
5,637.4
 
                 
Income from continuing operations before income taxes
   
663.9
     
597.3
 
Income taxes
   
229.3
     
211.7
 
Income from continuing operations
   
434.6
     
385.6
 
Income from discontinued operations, net of tax
   
-
     
16.1
 
Net income
  $
434.6
    $
401.7
 
                 
                 
Shareholders' equity
  $
9,483.4
    $
10,453.0
 


Aetna/7 
             
Summary of Results     
 
(in Millions)     
 
             
   
Three Months Ended   
 
   
March 31,
   
March 31,
 
   
2007
   
2006
 
             
Operating earnings
  $
435.4
    $
380.3
 
         Acquisition-related software charge
   
-
      (6.2 )
         Net realized capital (losses) gains
    (.8 )    
11.5
 
Income from continuing operations (GAAP measure)
   
434.6
     
385.6
 
         Income from discontinued operations
   
-
     
16.1
 
Net income (GAAP measure)
  $
434.6
    $
401.7
 
                 
Weighted average common shares - basic
   
516.1
     
567.4
 
                 
Weighted average common shares - diluted
   
536.4
     
593.1
 
                 
                 
                 
                 
Summary of Results Per Common Share        
                 
                 
Operating earnings
  $
.81
    $
.64
 
         Acquisition-related software charge
   
-
      (.01 )
         Net realized capital (losses) gains
   
-
     
.02
 
Income from continuing operations (GAAP measure)
   
.81
     
.65
 
         Income from discontinued operations
   
-
     
.03
 
Net income (GAAP measure)
  $
.81
    $
.68
 
                 
Shareholders' equity (6)
  $
18.51
    $
18.44
 


Aetna/8
             
Segment Information (7)     
 
($ in Millions)     
 
             
             
   
Three Months Ended   
 
   
March 31,
   
March 31,
 
   
2007
   
2006
 
Health Care:
           
Total revenue
  $
5,965.5
    $
5,495.9
 
                 
Selling expenses
  $
247.6
    $
221.4
 
General and administrative expenses
   
869.3
     
899.0
 
Total operating expenses
  $
1,116.9
    $
1,120.4
 
                 
Operating earnings
  $
422.7
    $
360.6
 
Net realized capital (losses) gains
    (2.3 )    
3.7
 
Net income (GAAP measure)
  $
420.4
    $
364.3
 
                 
Group Insurance:
               
Total revenue
  $
544.4
    $
535.2
 
                 
Selling expenses
  $
22.2
    $
22.1
 
General and administrative expenses
   
61.8
     
41.9
 
Operating expenses, excluding other item
   
84.0
     
64.0
 
       Acquisition-related software charge
   
-
     
8.3
 
Total operating expenses (GAAP measure)
  $
84.0
    $
72.3
 
                 
Operating earnings
  $
31.1
    $
32.2
 
       Acquisition-related software charge
   
-
      (6.2 )
       Net realized capital gains
   
.2
     
2.2
 
Net income (GAAP measure)
  $
31.3
    $
28.2
 
                 
 

 
Aetna/9
Segment Information continued (7)     
 
($ in Millions)     
 
             
   
Three Months Ended   
 
   
March 31,
   
March 31,
 
   
2007
   
2006
 
Large Case Pensions:
           
Total revenue
  $
190.1
    $
203.6
 
                 
Operating earnings
  $
9.1
    $
9.3
 
      Net realized capital gains
   
1.3
     
5.6
 
Net income (GAAP measure)
  $
10.4
    $
14.9
 
                 
Corporate Interest:
               
Interest expense, net of tax
  $
27.5
    $
21.8
 
                 
Total Company:
               
Total revenue
  $
6,700.0
    $
6,234.7
 
                 
Selling expenses
  $
269.8
    $
243.5
 
General and administrative expenses
   
934.7
     
945.3
 
Operating expenses, excluding other item
   
1,204.5
     
1,188.8
 
Acquisition-related software charge
   
-
     
8.3
 
Total operating expenses (GAAP measure)
  $
1,204.5
    $
1,197.1
 
 

 
                     
 Aetna/10                    
Membership        
 
(Members in Thousands)        
 
                     
     
March 31,
   
March 31,
   
December 31,
 
     
2007
   
2006
   
2006
 
Medical Membership:
                 
         Commercial    
15,351
     
15,176
     
15,141
 
         Medicare Advantage    
178
     
117
     
123
 
         Medicare Health Support Program    
16
     
15
     
17
 
         Medicaid    
158
     
110
     
152
 
                 Total Medical Membership    
15,703
     
15,418
     
15,433
 
                           
         Consumer-Directed Health Plans (8)    
910
     
614
     
676
 
                           
Dental Membership:
                       
         Commercial    
12,357
     
12,212
     
12,262
 
         Network Access (9)    
1,298
     
1,119
     
1,210
 
                  Total Dental Membership    
13,655
     
13,331
     
13,472
 
                           
Pharmacy Membership:
                       
         Commercial    
9,417
     
9,172
     
9,161
 
         Medicare PDP (stand-alone)    
321
     
278
     
314
 
         Medicare Advantage PDP    
137
     
107
     
115
 
                 Total Pharmacy Benefit Management Services    
9,875
     
9,557
     
9,590
 
         Mail Order (10)    
621
     
594
     
625
 
                 Total Pharmacy Membership    
10,496
     
10,151
     
10,215
 
                           
                           
 Medical Benefit Ratios (11)           
 
($ in Millions)            
 
                           
     
Three Months Ended     
         
     
March 31,
   
March 31,
         
     
2007
   
2006
         
Premiums:
                       
Commercial
  $
4,512.6
    $
4,296.5
         
Medicare
   
651.4
     
429.6
         
Health Care
   
5,178.5
     
4,726.1
         
                           
Medical Benefit Ratios:
                       
Commercial
    79.6 %     79.4 %        
Medicare
    88.0 %     87.3 %        
Total
      80.7 %     80.1 %        
                           
 

Aetna/11
Operating Margins     
 
($ in Millions)     
 
             
   
Three Months Ended   
 
   
March 31,
   
March 31,
 
   
2007
   
2006
 
Reconciliation to Income from continuing
           
  operations before income taxes:
           
Operating earnings before income taxes, excluding interest
           
  expense and amortization of other acquired intangible assets (A)
  $
729.2
    $
641.4
 
      Interest expense
    (42.3 )     (33.5 )
      Amortization of other acquired intangible assets
    (21.8 )     (19.9 )
      Acquisition-related software charge
   
-
      (8.3 )
      Net realized capital (losses) gains
    (1.2 )    
17.6
 
Income from continuing operations before income taxes (B) (GAAP measure)
  $
663.9
    $
597.3
 
                 
Reconciliation to Income from continuing operations:
               
Operating earnings, excluding interest expense and
               
   amortization of other acquired intangible assets (C)
  $
477.1
    $
415.0
 
      Interest expense, net of tax
    (27.5 )     (21.8 )
      Amortization of other acquired intangible assets, net of tax
    (14.2 )     (12.9 )
      Acquisition-related software charge, net of tax
   
-
      (6.2 )
      Net realized capital (losses) gains, net of tax
    (.8 )    
11.5
 
Income from continuing operations (D) (GAAP measure)
  $
434.6
    $
385.6
 
                 
Reconciliation of Revenue:
               
Revenue, excluding net realized capital (losses) gains (E)
  $
6,701.2
    $
6,217.1
 
      Net realized capital (losses) gains
    (1.2 )    
17.6
 
Total revenue (F) (GAAP measure)
  $
6,700.0
    $
6,234.7
 
                 
Operating Margins:
               
Pretax operating margin (A)/(E)
    10.9 %     10.3 %
Pretax operating margin (B)/(F) (GAAP measure)
    9.9 %     9.6 %
                 
After-tax operating margin (C)/(E)
    7.1 %     6.7 %
After-tax operating margin (D)/(F) (GAAP measure)
    6.5 %     6.2 %
                 
                 
Operating Expenses        
($ in Millions)        
                 
Reconciliation of Operating Expenses:
               
Operating expenses, excluding other item (G)
  $
1,204.5
    $
1,188.8
 
      Acquisition-related software charge
   
-
     
8.3
 
Total operating expenses (H) (GAAP measure)
  $
1,204.5
    $
1,197.1
 
                 
Operating Expenses Percentages:
               
Operating expenses as a % of revenue (G)/(E)
    18.0 %     19.1 %
Total operating expenses as a % of total revenue (H)/(F) (GAAP measure)
    18.0 %     19.2 %
 
 

Aetna/12
 
 (1) Operating earnings exclude net realized capital gains and losses and other items, if any, from income from continuing operations as discussed below. Although the excluded items may recur, management believes that operating earnings and operating earnings per share provide a more useful comparison of the Company’s underlying business performance from period to period.  Management uses operating earnings to assess business performance and to make decisions regarding the Company’s operations and allocation of resources among the Company’s businesses.  Operating earnings is also the measure reported to the Chief Executive Officer for these purposes.  Each of the excluded items is discussed below:
·  
Net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of liabilities.  However, these transactions do not directly relate to the underwriting or servicing of products for customers and are not directly related to the core performance of the Company’s business operations.
·  
As a result of the acquisition of Broadspire’s disability business in the first quarter of 2006, the Company impaired approximately $6.2 million, after tax ($8.3 million pretax), of the Company’s previously capitalized software, due to the acquisition of a more multifunctional system.  This is an other item for the first quarter of 2006 that does not reflect underlying 2006 business performance.

(2) Operating expenses as a percentage of revenue excludes net realized capital gains and losses from total revenue. Net realized capital gains and losses do not directly relate to underwriting or servicing of products for customers and are not directly related to the core performance of the Company’s business operations. Operating expenses exclude the other items described in footnote (1).

(3) Projected operating earnings per share exclude any future net realized capital gains or losses from income from continuing operations. The Company is not able to project the amount of future net realized capital gains or losses and therefore cannot reconcile projected operating earnings to projected income from continuing operations, or to a projected change in income from continuing operations, in any period. Projected operating earnings per share for full-year 2007 and second quarter 2007 assume approximately 536 million weighted-average diluted shares.

(4)  In order to provide useful information regarding profitability of the Company on a basis comparable to others in the industry, without regard to financing decisions, income taxes and amortization of other acquired intangible assets (each of which may vary for reasons not directly related to the performance of the underlying business), the Company’s pretax operating margin excludes interest expense, income taxes and amortization of other acquired intangible assets. Management also uses pretax operating margin to assess the Company’s performance, including performance versus competitors. Operating earnings used in the pretax margin calculation also exclude the items described in footnote (1).

(5) General and administrative expenses for the first quarter of 2006 includes the acquisition-related software charge discussed in footnote (1) above.

(6) Actual common shares outstanding were 512.3 million and 567.0 million at March 31, 2007 and 2006, respectively.

(7) Revenue and operating expense information is presented before income taxes.  Operating earnings information is presented net of income taxes.

(8) Represents members in consumer-directed health plans included in the Company's Commercial medical membership.

(9) Represents members in products that allow these members access to the Company's network for a nominal fee.

(10) Represents members who purchased medications through Aetna Rx Home Delivery®, the Company's mail order pharmacy, during the quarterly period.
 
 

 
Aetna/13
 
(11) Health Care includes all medical, dental and other health care products.  Commercial includes all health care products except Medicare and Medicaid.

 
ADDITIONAL INFORMATION; CAUTIONARY STATEMENT -- Certain information in this press release is forward looking, including our projections as to operating earnings. Forward-looking information is based on management's estimates, assumptions and projections, and is subject to significant uncertainties and other factors, many of which are beyond Aetna's control. Important risk factors could cause actual future results and other future events to differ materially from those currently estimated by management, including failure to achieve desired membership growth due to significant competition, reputational issues or other factors in key geographic markets where membership is concentrated; unanticipated increases in medical costs (including increased medical utilization, increased pharmacy costs, increases resulting from unfavorable changes in contracting or re-contracting with providers, changes in membership mix to lower-premium or higher-cost products or membership-adverse selection; as well as changes in medical cost estimates due to the necessary extensive judgment that is used in the medical cost estimation process, the considerable variability inherent in such estimates, and the sensitivity of such estimates to changes in medical claims payment patterns and changes in medical cost trends); and the ability to reduce administrative expenses while maintaining targeted levels of service and operating performance. Other important risk factors include, but are not limited to:  the ability to improve relations with providers while taking actions to reduce medical costs; the ability to successfully implement multiple strategic and operational initiatives simultaneously; lower levels of investment income from continued low interest rates; adverse government regulation (including legislative proposals eliminating or reducing ERISA pre-emption of state laws that would increase potential litigation exposure, and other proposals, such as patients' rights legislation, that would increase potential litigation exposure or mandate coverage of certain health benefits); adverse pricing actions by government payors; changes in size, product mix or medical cost experience of membership in key markets; our ability to integrate, simplify, and enhance our existing information technology systems and platforms to keep pace with changing customer and regulatory needs; the outcome of various litigation and regulatory matters, including litigation and ongoing reviews of business practices by various regulatory authorities (including the current industry wide investigation into insurance brokerage practices concerning broker compensation arrangements, bid quoting practices and potential antitrust violations being conducted by the New York Attorney General, the Connecticut Attorney General and others, and for which the Company has received and may receive subpoenas); and increases in medical costs or Group Insurance claims resulting from any acts of terrorism, epidemics or other extreme events. For more discussion of important risk factors that may materially affect Aetna, please see the risk factors contained in Aetna's 2006 Annual Report on Form 10-K, on file with the Securities and Exchange Commission (“SEC”). You also should read Aetna's March 31, 2007 Quarterly Report on Form 10-Q when filed with the SEC for a discussion of Aetna's historical results of operations and financial condition.
 
GRAPHIC 3 aetnalogo3.jpg AETNA CORPORATE LOGO begin 644 aetnalogo3.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X1:217AI9@``24DJ``@````'`!(!`P`! M`````0`(;1H!!0`!````8@```!L!!0`!````:@```"@!`P`!`````@```#$! M`@`9````<@```#(!`@`4````C````&F'!``!````H````,H````L`0```0`` M`"P!```!````141'05)I>F5R(%-O9G1W87)E(%-U:71E`/PR,#`V.C`T.C(U M(#`Y.C$W.C,P``,``:`#``$```#__P```J`$``$```!)`@```Z`$``$````9 M`0````````8``P$#``$````&````&@$%``$````8`0``&P$%``$````@`0`` M*`$#``$````"`````0($``$````H`0```@($``$```!B%0```````$@````! M````2`````$```#_V/_@`!!*1DE&``$"``!(`$@``/_M``Q!9&]B95]#30`" M_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3 M%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL- M#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,_\``$0@`30"@`P$B``(1`0,1`?_=``0`"O_$`3\` M``$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$````````` M`0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q M@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87 MTE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=W MAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4 MH;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=79W>'EZ>W MQ__:``P#`0`"$0,1`#\`]526'U7)RL'ZQ=)N]5PPG8-&>VL7XMMU%=UF[8*ZKW-J^U?1?ZGINLK_1 MH'%($:?-\O\`638^QTDES=_UTQZ+.K-LQR&=,J?9C/+H^TFIWV;(KK]GZ'TL M_9A_X7^<4>J?7"SI5_IY>/C-:ST?5J&8PY7Z7;ZC\?!]+??7CN?^?;1ZNSU& M,1&*9TK=7$.[TR2YO-^M.?CW=4]#I@OQNBD.R[C>&%S/3KR7_9ZO2?ONKJ>] M[ZGV5_0_GO4M]--5UGK=OUL^PLIJ=T\XC+VM]2#Z;[',^W:X_J>K[?3^Q;_^ M$]9+VI5>FW%N%<0_&GI4EEY?6Z\+J]6!E,%6/=C6Y->6Y^A=06G(H]+;^90_ M[1ZF_P#TBS\7ZT]2SVX]>!TL695N*W-NKLR`RNJJTO\`L=9O;3:Y^5E,KW^E MZ-?I?GV(#'(BZT[V%6'I$EB=.^LK.H7=/KKQW5C/JR;'^H8=59B/JQ[\=]8! MW_I;7>_?_@U:Z9U6SJ.-EVUT!EF-D9&,RLOD/-#W4M>7[/T?K;?W'^E_+0,) M#ZXVC'IZYM5FVWTL=S;:;7M997Z2,L M4A>VG8H$@7727*YG6[>G_6G-QZF/S,K)QL5N#@!Y:'OW93K[-SM]6/556&OR M+]JMY?U@ZM7GY.!A],9E6X6/7DWO.1Z;/>+/T%9-#W>JYU/Z#V['_P"%]!'V MI:5U`EOPJL.^DL`?6;(RWXE/1\'[5=E8;.H/]:WT&5TV_P`PQ]C:\G=D6O:] MGIM9_P!<0\;ZY8]CJWY..[%H?BY.0][W@O9=A/\`2ZAA.I8/I4M_3,M]3]+7 M_@T/:GV_'7[%6'HU4HZKTW(R78M&0RR]D@L:>[=+-I^B_P!)W\[L_F_SUDX/ MUL=EMZ?4 M;FNJQ_YN`=[]M;L:CU9/IT^A0][;/L_]-L_3W?S?IH\`C?'Z37I\47=5KW?_ MT/1.O=&KZUTYV$ZUV._>RRG(8`7UO8X/;97/YWYBIYOU2P\H=)9ZKZZND!C! M6`"+:F&E[:+Y_P`'ZF)0];CG-:)<0`.Y5U[9_.K=[V)VY)IEF007 M*?#./Z-?K8A^A9^K_^";/8MO[>T?38YO\`KY[59:0YH<.")4N'G8Y"?;R< M1CJ17RV>+Y9?UD2Q$;BK=H_1[J&X7L_?]K/43/Z!8 MWJN)U/%S'T/HH9B9%>QCVW4L=ZK6>[^8?O+OTC%L)*3CEW_E\JV@\U];L"WJ M]F%TJG'NW.M#[US*V65OJ:7/J:['N&SU:7/=Z-W_`%O](Q;"2/N$``?HWX_,JM_%P'_5 M-M-&`SI>;;A9'3A:VO(<&WE[<@MLR_M#+O;99=S:,ZS"RVLC0LNH?ML9M=[/]&M)<3]?NDV8?I_6KI1^S M=0PW,&18S3U&.(J8ZUO^$V.D3'7]V,ULI& M(O<#4C^#V#K\09+<=UE8R7M+V5$M]0L:8<]K/I[&N=])!ZAU/$Z>UGK$NMM) M%&/6-]MK@)V4U-^E_7_FZ_\`"/7!974K+;\;ZQ59#-V:]N1C8-+#]H<]E;<% M^-F97T_V=C9-5_IX]#?UZRVW_CJ>PZ!TB_&:[J'4G>OU;*'Z:QT'TV_2;BU; M?976S_">E_A/^MI\L$<<1.77]$>F4I_I?XO[RP9N*1A'4C4RWC&/Z/\`A2;V M"_J%S7OSJ:\<.(]*EKM[VMC7U[/YKU-WYM/L9_I;5;25'K?4F]+Z3E=0=$X] M;G,:?SGGVTU_]T M?HLASO\`BLENW^H^I;J\8^J^??T/ZTT.RB6$6NQ,Z3^^[TK?4=_P63LN=_Q: M]G4W,XACD*^4@5^UCPY..))T()!4DDDH&5222Y_J?6G,^MG1NC8]L>IZ]V96 MW]T4V_9F6?UK`^W_`*TG1B9$@=`9?XOJ02!OY?:]`DDDFI4DDDDI22222E)) M))*?_]+U59/UJKQ[?J]G5Y)>*'5^_P!/Z9$M]K)#MKG_`$/4_P`'_.+66)]< MK_1^KN5JYIMV5@L=M/NVNEINKJK):"UE;=M56/B4.$;A*/R M^J'EP=&G\/E.IQG\WIGK^E[@XN)FL+K\YO4^D]';)99<<[*B"/1P]ME;+&_N M6YUF)_F+=7*8S^LYGU@ZGU7IM&+=72YO3:GY-ME3FC'FW+]-M./D->RS,O>S M?O\`^TRK8QJ3^Z.O[Q],6\?S>/\`\8_2?L7U@=D-;%/46"T$"!ZC8JR&C_P* M[_KR]$^JO53U;H&)F/=NN+/3OUD^K7^BMGK,Q[G+`Z&6+337TM>/HY@CID%_X3K_`%H^M>77U;'^K?17-KS\ MBRME^6]H>*19!:VNIWMLM],^L_?[&5?\)9^ALY_U:S\7"MRNG=9ZA]OH8ZRM MUUPMK>YHW^G;BV,^S[+/H?HV,]->>=(RLO+^M].92UC\N_,?:QMKG-87.-C@ MU[V-L>QC6_R%Z98[ZYV5NK=C=,AX+3^L7]Q'_<1-RX_:X(QX1I<^*O4?^]7X MI^YQ$W\QC'Z./]7/K!D?6[%^R69MO2^H8S=UWV05@7U.AK;6?:*[W5>F[VV> MG^__`,)^CY+H&+=?]=V8SRVNQUC:]EN^M=%]5_ MJ']8.B]:Q<^V_%=13N;#B\CZF*1F1BXQ4N,!]%;T?J(QWU'K.6ZQSVN;>68V]H:#NK M:!B^ELL_/WUKSN_ZU]*\C+V/MR[]O\[_`#='J?S7L7.8_P!9>J_5SZUV M=%SLQ_4.FBYE9LR(=:QMS:WU6^M&]WI>JSUOS/\`1^FO1UX[]>?_`!9YO]?' M_P#/5"7+5DE*$@.'A)`KY?)6>1@(R&_$!]'O/KQ]:K?J_AU5X;&OSLO<*B_5 MC&LV^I:YOY[O>QE3/_2?IOATSH7[4Z?5U"SKW4,M^2S?Z]%QQJY_.]+$J8QE M6QWMV6M1_KET3H/4L6K*ZQE'!;B%P9D-,W8S(KJ#:W$&;#Z^;9B-?8ZS.5>G M_'*_7C/$1PT.$?I>+F=.^M?4^D_6A_U=ZK=]OQCW^CCW^B^VKW?3]EB]@3LX$!`B(O)` M<7;B6XB9&8)^29`\G__3]57*?7YS[J>G],K_`)S,R/;\6@4@?YV2U=6L7-_9 MG_.;`^U^I]J]&S[$#'H[Y_2?R_M'I_0W_H?^O>FI>7EPY(RHR(OAB-;E7I8N M8CQ8I1L1!KBD=`(7Z_\`FI^O=.;F]#R<.IFHJFAC0![J_P!)2Q@_-]S-B%]4 MLO[7]7L-YC=6ST2!_P`$?2;_`)S&L>MA8?U2'3QAY?[.-AQ_MENWU`T"?9IC M["[]7V_S>_\`2)7^I,2#\X,3TNO7'_H*X1[PD"/DX9"]>&_UAX>';)O96'Y!)DFZPF_*=N_ ME9%EBYKZXMOBW]IOZN.F>LS8,5F$:=TM]#5MGVST_7V^G]K_`,/Z?_!K=Z`. MK"RS[>[.^W?^]ZZ%#V]#UN7S?X/_=LG5UKZ*LBBS'N M:'U7-++&'@M<-KV_VFKQ;#MN^K'UG8ZTF>FY)KN,?2JUJM>&_P#"XS_48O7N MM#..$1@.O;?N;!Q1CNLB?=[>I.9C;?\`IKS#KC>A?M7)_;5O5OVC+?M.ZO#G MZ#/3_F+O1_F?3_FU/RLA$3XK,"/50E*F'/&S#A($Q*XV:M)7TX]%_P`8.+CO MTH?EMMQGCAU5Y=Z&T_G;7V>@[_A&+UI>;Y0Z..B4?\X']1=A^DS]CBYN(W)X M']"^Q/LR_P":]+U/MWZO_,^I^E]);&/1]=/L0->;E!L#8V[$PSE;?S0^QW4& MT>KM_P!/7O\`](AG/'P\1X91%>H3'%_6'I78@(\7#Z@97H?E/6+L]3ZEDCK' M3NDX#P+[7')S20';,2O_A%]'MRL>JVJFVQK+=GI[_7_P"MH\N8QXZ) ME<:],9'Z_P!U&:)EP;1J0/J+Z\O'?KS_`.+/-_KX_P#YZQUZ54.J_L.P/=F_ M;]=KG-P_M/TO;L96_P#97T?WW_0_X1>==9;T#]JY'[7?UG]I;F^O+,/=NVL] M+;Z%GI_S?I^GZ2'*2$9R.LO21Z1*7^$KF(\48BP/4#ZCPK?XQLW(R/K-D8]S MSZ&$UC*&=FA]==UMH;^^]UGT_P#@ZUZSC448V/5CX[0RBIC65,;P&M&U@;_9 M7FGUJ;T8M8WK=G4&]9,[7OKQ'6"B!Z7VFK"NKQ'T[_6]'],S-_G=_P"@]-7N MFU?6-O1ZC]JZQ;TCT_T;,?'Q*\CTOS/2L?F9'4-NW^;].KU_3_F4O6]S=P9(W$$AO>!R?Q7EWUG;]2'.Z>.E6WTV>@ST78%;;6[-SO1^T,N MNQK_`+?ZN[_"?:O^Y7O]-=9]6!BCJ>4,]V2_ZQBMOK.SFULL.-(]/[#7B/NQ M&X'K?SOV:S^E?TO_``2&7-T96US+"!);F,N``!865H@````````M5H``+QG``"2,&UF=#(` M````!`,)```!`````````````````````0````````````````````$```$` M``(```(D!!T%V@=I"-D*-@N%#,<-_P\Q$%X1BQ*W$^(5"Q8R%U<8>1F8&K4; MTASO'B4?62"'(;(BVB/_)2,F1"=F*(8IIRK'*^@M""XH+T@P:3&),J8SPC3> M-?LW&#@U.5$Z;3N)/*4]PC[>/_A!$4(I0T)$7$5U1H]'J4C#2=U*]TP232Q. M0T]94&]1AE*<4[)4R57?5O98#5DC6CI;45QF77A>BE^;8*UAOF+/8^!D\68" M9Q)H(VDS:D)K4FQ>;6=N<6]Z<(-QC'*4<-ZR'O-?,Y] MS7[,?\N`R8''@L6#PH2_A;N&MX>SB*Z)J8JDBYZ,F(V1CH:/>Y!PD6226)-, ME$"5,Y8FEQF8#)C_F?*:Y)O6G,B=NYZMGY^@CJ%\HFJC5Z1%I3.F(*<.I_RH MZJG7JL6KLZRAK8^N?:]KL%FQ1[(VLR2T$K4`M>VVVK?(N+6YH[J0NWZ\:[U9 MOD>_-<`BP1#!_L+LP]K$Q\6UQJ/'D@#IP4L!H0'OPCG"@0+%@P<#1X.'`\9 M$!<1%!(0$PL4!!3\%?,6YA?8&,P9UAK>&^$:2)M)G4J?2Z-,IDVJ3J]/M%"Z4U>\5_U8/AA_&,`9`-E`67_9OQG^FCX M:?5J\VOP;.YMZV[H;^5PX7'>O>*5YFWJ0>X5\>GUO?F1_ M6(!-@4&"-8,IA!R%$(7^ANV'VXC*B;B*IHN5C(.-<8Y@CTZ0/9$LDAN3"I/Z ME.F5V9;)E[J8IYF3FH";;9Q:G4B>-I\EH!2A!*'UHN:CV*3*I;VFL:>FJ)NI MD:J'JW^L=ZUOKF>O8+!:L52R3[-,M$FU1K9%MT2X1;E&NDB[2KQ.O5*^5[]= MP&/!:L)RPWO$A,6*QI#'ELB=R:7*KW&O=>=Z&WY3@G.&BXJCCK>2RY;;FNN>]Z,#IP^K4Z^7L]>X$ M[Q+P(/$L\CCS0_1.]5GV8_=J^&[Y;_IL^V3\5OU$_B__%___```"!0/8!6@& MQ@@&"3(*4@ME#'(->`YZ#WH0>A%Y$G43*6(M9C5J/6Y%8QZAWN"?'Q]=GYO?VF`88%:@E(0^A36&*X)#(H"BO>+ M[8SBC=B.S8_#D+F1KY*EDYR4DI6)EH"7>)APF6J:8YM>G%F=59Y2GU"@3Z%/ MHE"C4J15I5FF7Z=FJ&ZI>*J"JXZLG*VKKKNOS+#?L?.S";0@M3BV4;=LN(>Y MI+K"N^&]`;XAOT/`9<&'PJK#SL3QQA7'.R8+*ILO*S.W.$,\RT%31=-*4 MT[+4S]7KUP;8'MDVVDS;8=QTW8?>F-^GX+/AON+'X\WDT>72YM#GS.C$Z;KJ MK.N;[(?M;^Y8[USP6_%6\DSS/?0J]1+U]O;6][/XC?EB^B_Z]/NQ_&;]$?VS M_DW^X?]Q__\```'9`XT%"094!W\(E@FA"J0+GPR3#8(.<`]?$$P1-Q(A$PD3 M\!36%;L6GQ>#&($9?1IT&V8<51U!'BP?%R``(.HATR*](Z8DD"5Z)F0G3B@Y M*24J$"K]*^HLURW$+K$OGC",,7DR9S-5-$0U,C8B-Q$X`3CQ.>(ZTSO$/+4] MICZ8/XI`?4%O0F)#541)13Q&,$E5M5E]745A#635:)EL87`E<^EWK7MQ?S&"]8:QBFV.)9'AE9F949T)H M,&D>:@MJ^&OE;-)MOFZJ;Y9P@G%L>H9[;GQ6 M?3Y^)7\-?_2`VX'"@JB#C81RA5>&.X<@B`6(ZHG/BK.+F(Q]C6*.1X\MD!*0 M^)'>DL23JI21E7B68)='F"^9&)H!FNJ;U)R_G:J>EI^#H'&A7Z)/HS^D,*4B MIA6G"*?]J/.IZJKBJ]NLU:W0KLNOQ[#$L<*RP;/!M,*UQ;;(M\VXT[G;NN.[ M[;SXO@2_$<`@P3#"0,-2Q&;%>L:/QZ;(OLG6RO',#,TJSD?/8]"`T9_2O]/@ MU0/6)]=,V'/9F]K$V^_=&MY&WW/@H>'/XP+D3>69YN?H-NF&ZMCL*^V`[M?P M,?&0\N_T3?6J]P3X6OFK^O;\.OU[_KO___\`@`"``.6T?\U_5,P_?Z5^P[*, M?Y1^:9A_?YY^3'WC?\%^8V)!?_Y^DD1A@']_!1]D@?Z`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`!]L;[-AP5]5Z:UAC!],XX:A81] M2'30A/Q]C%IKA)M]Z#V.A)]^BQB+AGJ``>O)AZZ)"-4`AJ.'?;V-A;F&(:5^ MA/B%`XS0A&2$*G-]@_2#B%D/@ZB#!SPY@[B"X!;YA7>$`^G[AG"3^--3A7>1 M=;P0A)R/&:04@_6-$XN)@W6+5G)5@Q>)U5?_@MB(?#LL@NN'E!6(A'N'J.A2 MA7.>^-&RA(.;@;I_@[*8.Z*A@PZ5.HHX@J"2H7$I@E"00U;W@AN.'#HT@BZ, MEA0X@XF*R>;(A*JJ&-`R@[NEK;D&@O&A@J$_@E6=I(CN@>.:$G`+@:.6YU8" M@763_SE3@8:2#!,5@IJ,Y^5CA`RU8L[6@QVP`[>U@E*JZJ`%@;FF+H?5@4ZA MQF[]@0F=O%4?@..:,SB)@/.8.!(?@;R,0>0O@XO`VLVL@IRZ@K:2@I[T M@3:NWX;H@-.IL&XQ@).D[51<@&6@V#?=@'2>6!%4@0.+M^,I@R3,E;03K3$@1/(89TU@'3!%(5.@!*Z>FS5?]^TS5,\?[JP2#;1?[RE M$!`J?_2*[MT\DF%\F,=KD'I\0[%6CK)\$)K'C1I\$8.7B[=\26N>BH)\L5)U MB8A],C:.B2=^`1$RB]9_WMM&D2V&R\8%CT*%A+`JC8.$;YFRB_R#D(*#BJV" M\FJ,B8V"B%%>B*."0#5ZB$F"8!`$BIB#AMFSD`"1),2=CB*.[:[]C&.,WYB` MBO&+)H%5B;.)LFEJB*:(?%!*A\N'=C1VAWF'!0[ZB5:&N]A'CPB;DL,NC3*8 M>ZV!BX:5EY<>BA.2_8`7B.B0OFA3A^:.O$];AQ.,_S.=AL*,'0X4B"B)A-;I MCDJF%<'1C'BB)JPDBM2>;VDVU MA=V8^3(LA8J7\@RHADN(C]20C3.[I;^2BV>V!:GRB<*PII.^B%NKI'T*AS"G M"&6>AC:BYTT,A5^?KS&=A0N=/PP>A9>(,=.CC,O&Q[ZSBP/`2:D6B5ZZ%)+G MA_2T27Q"ALRO!&3VA=RJ=TR'A06G93$DA**A.@NNA02'YM+@C'+25[W[BK#* M\:A=B0W#X9(QAZ.]4WN=AGJW?&1IA8NRQTP-A+VN9S"WA%R@\`M5A(Z'JE&![)GD5DD5[>&)ID&5[^4IRCMI\DR]CCC5] M?@I^D!]_P,LZFN*$_;=FF".#YZ,!E9F"_(WZDTV"2W@KD4.!V&%\CW6!FDE^ MC?>!@2YYC5>!XPG/CIN#",G3F=^.K;8%Z,BHF.>8CK3CECV5SJ"GD[V3-(N[ MD7*0[78#CX:._U]_C=*-4D>QC&:+^RS>B\R+S0BOC!^%W\=\F"RBAK/&E82> M^I][DPN;K(J$D-*8JG3LCMF5]%Z/C3&3H$;NB\61Q"P[BR>1O@@\BR&%D<9? MEYNLI;*RE/6H69YLDGZD2HF$D$J@C70!CE.=(UVXC)V:)T9!BS27]RNNBI27 M.P?;BDR%4,5FER:V[+')E("QWIV)D@BM#HBJC]6HFG-`C>6DCUT3C#"A$T6Q MBK2>TRLZBA*;R`>+B9N%&L22EL/!>+$'E!Z[I9S)D:>V%H?NCW*P[G*/C86L M55Q]B]JHF44^BERF02K9B:B<^0=*B0N$[L/BEF[,>;!GD\K%V)PHD5:_A8=. MCR.YLW'^C3:TJEP#BXVQ$T35BAJL0BI\B6FJH(*6SQEUV')U>*E.^&9D"\ MDNZ%Z":.DCB&6P0OD+2"U+E\HQN5]:;]GZ.3>I/_G%F1.8!?F4Z/,VOUEIV- MD5:ME#2,,4`"DC2+.27YD7>+V0/]CY*"LKB6HE6?:*8*GNF<,Y+^FZJ9/W]6 MF*:6BVL$E=B4+E79DWR2/S]2D7Z0["5ND+^15@/3CIF"EK>CH&6HYE5:;(E4BDNN8K#[#D.R7/R4!D">6"P.OCRO:1MG>&N'I%LFIVIQGW*EZ"ET6F6E.NB4E26DH"?@SY/D&R>5"2LCZ"8 MS`.1C1J":;8/H/Z\MJ/&G8*W89#*FCVR7'TLES^MS&D!E(ZIX%07DBVG#3WO MD!*DPR1ECS"8FP-YC(V"6;5QH*_'+*,\G2W!%Y!!F>J[7WREEO"V/VB(E$"R M$E.SD>"O1SV;C]*IJ"0?CO28;`-EC!V"3*X>K_YYY)PIJ]YYMHH0I]YYLG>* MI!=YYF1'H)AZ4$_YG7-ZYCH?FO9[C2`IFIA\<0``E=-_RJS.KRB"@YMHJN2! MF8E^IMJ`X';[HQ.`8V.HGYN`)D]3G'^`(SETF@6`3!^AF9:!%P``E(Z``*O? MKCV++IJ*J?Z)C8B]I>V(&G8QHC"&^V+DGKR&($Z?FZ:%CCC5F2R%2Q\NF*N& M1@``DW"``*L2K6J3YYFJJ3>1FH?,I3"/A'50H6B-O6(2G?R,44WHFNB+.#A! MF&J*HA[*E]>+LP``DGB``*I!K,J_E[B0:QYUEQ2080`+D9*`!ZF0K"RES)@OI_RB,89(H_F>XG/* MH#6;[V"JG+*97$ROF8^7:S=-EPJ6Y1XHEE^46``;D,2`$JCBJ[FO`Y>BIWVJ MN(7"HW*FPW-`GZRC0V`IG#:@3TQ!F1R>.S;VEH"=?1WSEX5#HPVNYW+(GTBJY%^[F]:GJ4OAF,6EXS:PEB.BZQW,E4^4 M)@`SCX^`(J>YJQ7"7I:FIL2\JX36HK:W<7)BGO:R^E]CFX:ONDN9[!Q?PHG)[O@``D2B``)ZFN;:!I(Y"M,*`O7UBL`6`#6OS MJXQ_GEFXIV1_PH3N`N@``D&Z``)WWN,N)U8V:L]Z( M27S/KQJ&[FM5JJ.%[5D>IGJ%-$7AHL:$S##ZG^R$Q!>!H!R&!```C\N``)UH MM_.2$(SXLP^/YWP:KE*-^VJJJ/J```CEZ``)O(MC:KH(MPL42GI7J8K(*D$VDO MJ`2A!5ET0YH`B=22_$G/"<)Q<5G*B/FP``C@J``)M*M=>TC(LBL-2O MVWI7K`.KJVCIIWFH,5;?HTNEL$/\GY6DGB^/FP``C<6``)K9 MM8:]ZXK+L'2X@WH.JZ&SMFBLIQNOXU:RHN^MH$/?GSBJIR^1G"^@*1N)Z%W&#; MLW6$\T^AKI^$63U2JEJ$&2DCITJ$3@^OJ$^$[@``C,&``)"!PJF0:X#HO2.. M7W#IM[R,E6!KLH:+)D\ZK;**)3T`J6J)DRCVIDB)XP_:IP2)`@``C(R``)`L MP>B83X"4O%N5M7"2MO"3=&`+L;N1E4[HK-:0)CS#J)*/:2C7I6.0&Q`$I>&* MU```C%Z``(_'P5"@8H!"N[6=-W!-MD":WTZ)JY.= M!SQ]ISJ0248AM16/)#3$L%6.WR%:K2"/>PG,K$*&H```BEB``(0= MR]2>(750Q:2;&F8HOXZ8D%:#N:^6F48XM"^52S3CKUV52B&2K!B40`HTJQN& MY@``BFB``(/^RRRESW5*Q.^B.68WOLR?.U:AN.F<_49T9YBMKW>YQY MI<+]>_9YT:I]?%AZ')%P?,-ZBG>[?3M[%ESV?<-[JC_6?GA\7!L6?]%]#_!< M>9"$[]DZ>@>#Z,%Q>H"#!*D5>OZ"3I`=>X6!R'9Y?!>!9%NZ?+*!"CZ7?6>` MU!EU?E^`V^YJ>":0=-=H>*R.4;_7>3>,4:>2>FF))74W>Q&'U5J1 M>[J&E3UV?&N%B1?V?.^%&.R8=OB!J5T:8!>+R3#8U2>6^0 MIG/U>B>.:UEU>MN,33QL>X6*@A::>XB(W^KP=@6GH]0`=I.C;+R*=RV?;Z2% M=]>;N8OO>)&81G*^>5J5+%AG>A>2.3MU>K>/U15D>E>,%.F"=4NS4M*9==6N M(KLI=FRI**,U=QFD?HJ]=]J@(G&8>*><$U=L>6N89CJ6>@*5KA16>6>-P.A0 M=+F_'=%M=3VX]+G^=!:C3E:1>-B>ZSG6>6:< M*A-R>*:-)N=7=$S+"]!Y=,K#ZKD&=5*]`*$9=?FV=HC,=L2P:&_H=YZJX57G M>&2F'#DS>..AT1*Y>`B,J.:1=`/7*<^X='G/#+@Z=/;',:!%=92_R(?_=ERX M]V\O=SBRZ%5&>`"N+3BF>'>F31(E=XN,1.'CA"YWY@3"`'C?N@8.`+!)X@R"`IMZ$ M@4J-J\E.@.&+WK-1@(>*+YQG@%&(PX34@#*'C&R&@"Z&@5,,@$"%CC;G@(V$ MXA$\@;*$<]SG@"J8E\>D?\65U;&J?W:3.IKJ?T:0U(-\?SR.PFM8?TB,WE(( M?V2+)#7Z?ZR)X1`K@'6'P=M@?SVCDL8D?MB?ZK`R?I"<:YF!?FF9)((O?F&6 M%VHZ?GZ3:%$5?J.0\S4A?N*/2@]`?V6*4-H-?H6NK<3:?B"J)*[M?=6EO9A+ M?;&ACX$5?;"=J6DR??C*57PY[?H")RMCS??.YZL/(?8ZT M@:W:?3ZO,9<\?1BJ((`C?1ZE;VAA?3^A)T]\?6>=C#.X?9F;9@W8?<.)7-@0 M?87%6<+K?1^_#JSR?,BXUY90?)FRXW]$?*"M;6>=?,NHE4[:?/>DV3,L?1N@ M6`U3?2B)`M=D?371%\(\?-#)YZPP?&["QI6"?#2[]WZ$?#BUS6;W?&6PETY4 M?)>LEC*Z?+>B3`SH?*V(NM'!C5%VDKVUB^MW!JD#BJEW?I-^B8YX"7TQB)=X MLF8%A\5Y>DV>ARAZ23(XAR5[,0S6B21\>=`\B_&`Q[Q\BIF`/J?:B6-_SI)H MB%5_?GP?AVY_5V3[AJY_44R4AAY_7#$UAAI_F`OLAXN`6L[BBJF+&[LAB5^) MG*:LB"N(-Y$OAS"'#7KRAEB&$V/BA:F%1DN/A2:$EC!$A2&$1`L>AB2#PLU^ MB8^5=;FQB$F3%Z4FAR60VH_-ABZ.SWFQA6R-"V+'A,R+=DJVG>"@^^; M;V#3@UB87DC[@NJ5XRX'@M"5#0E1@P"&3,GYAW*U&;8WAC&P3J&QA0^KEXQU MA""G&G:G@V:B]V`7@M*?1TA5@EB<=2U[@CB:20CF@D:&!,DLAP.__[5MA<6Z M9Z#?A)^TWHNA@ZFODG7>@N^JPE]G@F:FI$?'@>VC^2T$@;J><`B/@:Z%RHKJ@TNX:'4U@HZS`%[5@@:NM4=*@9.JUBR7@5Z> M)@A*@36%F\('EKUUA*]9E(IV"YP-DH-VEX?PD*YW-G+XCP=W\UT&C91XRT6Y MC')YIBL#C$YZC`:IC/]\G,"\E7U_+*Y3DU!^RYL4D5-^?HU^ M3UP(V*T8DC2'G9G[D#:&=87D MCGB%B7#_C.J$QELHBY*$+T/QBH&#NBECBDV#N06^B@J#)KYODT&2IZODD2B0 MF9BYCS>.H83(C7",XV_KB_2+9EHPBJB*'$,9B9Z)$2BJB66(YP5?B->#H;U' MDF>9CF&7`X.5C*J4A6[9BRB205E`B>N04D)3B.2.QR@(B*". MR@4-A]"#:KP\D;^FAJG%CZFB^):0C;R?AX*7C`><2FWPBH>945AMB4"6NT&G MB#R4WR=\A_"4.P3(AO.#/+M;D3FPIZCICR6L7Y6TC36H+('`BWZD-&TLB@2@ MF%?&B+V=@T$9AZF;E2<+AU68O@2/ACR#%;JDD,^[`:@VCKVV`)3YC,JQ#X$$ MBPZL7FQYB92H,%DUT"=AT"BW":JAM::)`1@A::"]KH:D'S%NJ>GCFW` M`Y1;C'BZ4H!@BK:T\FOBB3>P3E:GA_NM$D`MANRHQ"9(AH&9X@0[A2^"W;+# MH'ITPZ%(G8AU3H\\FL=UXGQHF#UVC&BQE>EW4U/HD]IX,CVADD5Y#"-GDDEY MU`%*D%E\NK&PGV!]YJ!]G&M]F(Y\F:Q]8WNJER1]46?LE-A]9E,DDM)]G3S; MD4!]X2*YD3-^5`$LCLQ_W;"[GD:'#I]YFUR%](V/F)N$^7JVEB"$,V<%D]V# MG%)0D>&#,3P=D%."[B(>D#6#.P$1C6^`N:^\G5.0,9YHFFV.8(QNE[2,MGFW ME3"+,V83DOJ)^E%^D06(\SMNCWB(.2&5CTJ(LP#ZC$"`J:[5G'"9BIUVF9.7 M!(MREN*4IWBSE&62-W"$7CFV.+P#FBSV`G*WS MF\RC")RLF.Z?T8JIECB2 MX`#6BF.`D:TRFTVLH)OLF&^HP8GHE;>D_G9D]NCPJ;\3G" MC6J;`B!5C1:5W`#(B:Z`AZR0FNNV:IM0F`VQXXE(E5&M=7:%DLZI5F,@D).E MRT[FCJ>C2CE9C0"A6R`,C)"5JP"]B1N`@*P4FIS`G9K3E[Z[;XB^E0"V5G7W MDGBQHF*?D#FMS4YZCDRK73C\C*ZF91^^C#Z5=@"TB*6`>J0)JI%T.9.?INQT MO(*QHWQU3W$%H$5U_%YSG4IVQ4J\FJAWHC57F+YX:QM`F6MX[```C9Y_$:,P MJ99\XY,+I>=\FX(DHG!\!H3EAJ(.```BG>``*#CIM26YI"7HS64FG^IG\*2?VX" MG(B0GUN@ECF3Y3*[E#N3B1F$E%:0Z@``B0>``)^= MI:&H\H]GH@6E9WYWGHJB!FS(FT:>\UINF$Z<6TEGUE^"CE$:^E4RB#C(1 MDRZ?=!DFDQ"1`0``B`N``)ZJI/F[WHY]H52W(7V$G="RBVO7FH.N>EF0EX:K M@T9LE.^I0C'.DMBAK!CWDK60X0``A["``)7QM0ASQ(9]L+AT-W:0K*)TPF7O MJ,5U;%1GI2MV,4&BH@AW`RSPG_AWK!)NHAQWK```B7Z``)55M")\`88?K\5[ MM'8TJYY[D&6.I[)[EE/[I!%[R$$XH.E\&BR/GLE\:1)4H)U\KP``B,2``)35 MLQF$+(6,KL.#-'6PJI."963\IJF!V%-OHP>!?T"]G^"!6RPOG;2!9Q(_GS^" M"0``B"&``)1.LA^,4X3LK<^*PG3[J:2)8&19I;&(/U+6HAB':$`]GO*&V"O2 MG+J&P1(KG@:&R@``AY.``).[L5.4DH14K022<'19J-R0B&.RI.F.WU)*H4"- MA#_(GA^,H2N!F]N,J!(;G.Z*X@``AQF``),JL+><^8/+K&::2W/4J#B7U6,O MI$&5K5'.H)23Y3]FG5F2PRM`FPN3$Q(0F_*,-@``AK.``)*^L"6EA8-@J]6B M2W-HIZ6?2F+&HZVBL0FD:8E!()FPR,,@``AEZ``))3 MK\6N18,;JVRJ>',FIRRFXV)XHQ^CR5$=GVVAC3[.G#V@NBK:FS$7+5IM"N\6(JHK^K?%#F]2FS2J\ MF62:,,```A>*``(AVO^5S47GANO5SK6K9MD-T*ULGLOP5[+GFYN@AZU&JNM3QZK%KT ML*MZMDI/K&YZ[CA?J-5[0R0TIL=[@0J?J"Y\8@``A;:``(?>O?*"Z7EBN/V! M]&I>M":!+EJ6KX^`M4GVJTR`=#@:IZR`;"03I8&`E`K?IH.!)@``A6N``(>7 MO.>*F'D!M_6)&VGGLR*'U%HLKH&&UTF4JD&&+3?/IIV%U2/RI%N&&`L7I0>% M40``A2F``(<^O`J28'BEMQ:08FF$LD&.IEG`K9Z-,TD_J4Z,'#>/I:R+EB/7 MHU:,/@M*H[F'H@``A/&``(;?NV*:4WA0MF>7UFDUL8B5G%EUK-^3O4CYJ(R2 M53==I-.1QB/#HFN1Z`MTHI2'OP``A,*``(:'NMZB7W@)M=J?9&CUL.^MM]TRR]%LR%U9!L& ML?AU:P-OL$UWB0``@R2``'MHRD!ZB&VKQ,)Z$5]>OVMYV5!PNDEYVD"9M8=Z M#2]2L:AZ5AM'L#%Z7P0+KB]\1@``@R*``'MRR1*!V6V7PYZ`V%]'OCV`#U!. MN0M_H$!]M#I_;2]0L$=_=QM]KI)_JP27K$F`=0``@R&``'MPQ^B)%&U]PG.' MGE\7O1&&9U`EM]2%A4!>LP&%`B]*KP*$WQNMK1V%A`42JIN#;@``@Q^``'M; MQNR096UEP7".@%[^O`2,Z%`"ML*+I4!/L=^*SR]0K=R*K!O?J]"+,`6!J22# MN0``@QZ``'LYQB67Y&U4P)J5D%[WNQ^3CE`#M=61]D!/L.Z0["]AK-*1`1P5 MJJ:0"P7DI^&#^P``@QV``'L7Q82?=6U'O^J1Q+J:.3(08[ILZ$-P``@QV``'KVQ0:G,&T_OUNC_5[\N<&A+%`6 MM&&?%$!GKW6>62^-JU:N$:@``@QR``'KDSB^YJK"@11RSJ#&39P;(I4:$E@``@QR``.8? M=G!S&-`;=TMS\;F`>!]TS*(J>.IUKXHD>;)VH7%C>G]WHU>&>T]XGSLO?#%Y MEA:=?2%YZ.0/=(=^:,YK=8E^&[?Z=GQ]Y:#+=V5]RHC=>$M]S7`N>3-]Y%9; M>A5]^3H'>N]^$A4@>U1]P>(Q`:$0E4^>/:#>3CY><2"Q!/$>=6""^!I<9.5.,K-:,=FVR=O:*PE0J=_*)(3?^>+*'MQ*4>(N%[-[)<'6@G1:5,C=PN.^C<5=[N,_A&/=W&)/]UL M;YBL#H-W=`^;M&M8=368,U(N=D&5#S9"=N&2 MQ1"T=H2+2]Q.;NNWC,;!<`2R6["+<16M,9F^S3T=86>M0]J=1^*;-K+;AO.QL5$;RG'Y*[K<"'`\Y?_ M<2>Z-H"[JO.?9=\?)7^??HU]-#.0?Q)] M<@Y!@$A]@],`>]*'4+\'?`*&0JI!?#.%1)2!?'&$;WW^?+N#O6:B?16#)DX+ M?7:"F#*3?>V")0U,?M*!@]%N>H:2&+UE>KR0&:BA>O>.,),->T",:7RJ>Z&* MW65X?`R)7*:J:"Z>V709&D M>C^4F'MF>J62'&1;>R*/YTP9>Y.-X3#<>^J,?PO"?'>'\\ZS>)NGTKJS>-2D M'Z7R>16@<9!R>6J=:9D6-6>E.6A$L^>LR3YC`A>Q62@@LI>XV'B\VN M=_&RT[FP>"JN3J3J>&6IOX]L>+FE5'E:>2RA-&*%>:Z=<4J$>B&:2R^#>ER8 M<@JJ>LN'-LSD=W.]\;CC=ZJXH*00=]RS-8Z+>">MZWB!>)NI"6'$>2>DMTGE M>9RA:R[\><&=3@I">BV&\,Q5=Q[)/KA*=U'#(Z-?=W>\X(W+=[6VPG?(>"2Q M+V$@>+"L>TE4>2>H\BY]>4&?;PGP>:^&N,9^B!APBK/\AS-QOJ"2AG)RVHP; MA=%S[G:WA4=U"V!Z@VA\:2S8@[)\P`@OA*I]=<02 MA0Z$^;&HA%R$,9Y?@[.#8@SF!"\*M@\>/*K`Q@Q:-C9S)@GR+]XAQ@@"*?'-"@:B)-ETU@6N($D75 M@4J'$RLL@7B&?@<4@?B$*,%4@KV98:[8@@V6_9MU@7J4G8VCOJVX@4"@EII7@*N=9(84 M@#B:17$76EM1?[:4PD1$?Z&2M"G7?["2$P9$?_Z$/;]$@4FN-ZS+@)^J M3IED@`6F2X4@?XZB6W`]?T2>N%J2?QB;@D.F?O:9(BE1?OB70@7V?S^$"+Z0 M@,ZXVJP0@":T,IB9?X2O8(1.?P*JGV]S?K>F3EG8?I6BJ4,,?G>@<"C??EZ; M@@6V?J.#W+X4@'C#P:N"?].^8Y?L?R2XP8.3?I.S-6[&?D"N25E%?B"JG,"AY?>:;7@6#?B:#NK=3BI5UAD#OB>!VI":!BCMW@0,JBB1YO;98C^%Y4Z5#CD=YGI,>C-1YZ7_Y MBX=Z/VO6BE]ZJ5:JB69[)$`*B+5[F"6RB/I[]`+;B(1]:;5)CHN"ZJ0,C0*" M79(#BY*!TW[7BE.!:6K,B3>!&56[B$J`XS\VAYZ`NB3ZA\Z`N`*5AQ:`HK0L MC4V,E:+4B\N+/I"VBFJ)Z'VYB2J(M&F]B!^'K%3.ASZ&QSYKAIBÒAK:% MY@)9A=F!EK,%C$N62:'"BLN4.(^1KB,LA.R1(0'Y@^6!5K$UBNFJ#I_KB7&FEHW`B`^C#7J\ MAMF?G6<%A=6<>U)JA/V9U#QUA$J8/B+`A#"5G0'5@R>!/;"2BG*T)Y]`B/ZP M`HT)AY:KOGH"AE:GEV91A5"CX5'&A(.@]#OP@\Z?7R)A@Y27/P&X@HV!*;`@ MBAJ^BYZ\B*JYPHQNASNTQGE=A>^O[F6YA.*KP%%$A!.HYCM_@V2E,2'_@R*6 M_`&@@A*!&:B;FNEO")B.F'-P08>EECQQ:76PE#QRC&*UDFASMTZ2D-5TYSC4 MC\)U]!ZCD(9VA```BG)[1:?*F9UX)Y?2ESUX@(;7E0YXW73DDPUY1V'KD3MY MQ4W0CZQZ4#@9CI5ZS!X&CS5["P``B-E^DZ;OF%>!.Y;1E@F`RH7ID]N`97/M MD>6`'&$%D!U_\4T!CIA_WS=CC8%_UAUWC?Y_\P``AW*``*7UES:*0)7"E.J) M'X3&DL>(#7+VD,V'#V`;CQ.&04PYC9:%E3;`C'Z%&QS\C-V%9@``ACN``*4+ MEBZ3<93.D^R1HX/+D="/XG'VC]R.,U]&CA:,LTM^C*6+?38JBXR*KAR/B]"* MXP``A3"``*0TE6^H1F_' MC@2DIUTMC$2ABDFFBL^?9#2TB9B=V1N+B8>2GP``@OV``***E!:YFI)(D>"U M6X$CCZZP\V\XC:&LOURJB]BI4DDWBF"G2#12B3"BUQLWB1B29P``@H2``)I2 MI-MNA(L\H;IOKWM9GMUPTFI[G#AQ]%B5F<9S&T5NEZ]T/S!REF5U*!7_F$UU M*```AB!^:9FRH[MW+HJTH*1WA7K#G<%WZ6GDFQ%X7E?\F)MXYT3=EH)Y>B_J ME2IY[16FEM1YW```A0"``)D+HH9_P8GJGWU_7GH*G)9_#6D?F>U^X%=&EWI^ MT$0[E69^V2]BE`=^Z!54E7A_"```A`2``)A*H66(2HD-GF.'1'D8FX:&4VA. MF-F%A%:`EG.$XT.3E&2$:B[>DO^$*Q4'E#Z$@```@RB``)=^H'R0W8A#G7R/ M0GA'FJ&-O6=TE_>,6%71E8&+&D+\DWN*-2YLD@R)T13*DQN)0```@FR``);7 MG["9JX>7G+F7>G>7F=^55V;)ER^34U4OE+>1C4)[DIN00"X,D2>0#A22DA2- M1@``@DY6? M44&'D8*>$"U8C^F;X!0YD(2-K```@."``)5UGF*T\(8[FVNQ*78BF'BM1F5! ME:JIKE.TDRJG#D$OD1*E.BT.CWV>=A0"D`R-AP``@(N``(R$G)EXY`TZGN)X MT0``@<6``(NZK0U^77USJ5A]_VY\I<)]NUZ+HFE]HDVGGU9]J#MYG,=]QBH\&+M%U! MH&**@4R)G4R)B3J-FL&([":4F3&(_PT_FER'/0``@!J``(H0JD&6Q'NNII:4 MS6R8HP62[%RZGZ&1.4P)G(6/T3HRF=V.]"9;F#^/6PU"F2>(]P``@`"``(FH MJ9Z?('M`I?B2ASEOXGF*?(TM*FSF=.3F*F)FEP@$29JF!QC3,!IY-R>!Z[IM%RP06]IS]S;0``@`"``'\SN1]U4'''M,EU MC&.1L)YUZ52*K*EV8D1VJ0EV\#+KIB9W=1[$I3!WD@8@I2%XQ0``@`"``'[Y MM_%\_G%OLY]\G6-%KV=\7E0SJVA\5$0JI\)\:S*VI-5\EAZYH[5\H09RHS9] MHP``@`"``'ZJMK^$DG$%LG&#L&+&KCV"\5/*JCB"9D/)II:"%#)RHZ2!\!ZD MHF*"%@:VH7^!Y```@`"``'Y,M;^,.'"DL7**X6);K3Z)L%-5J3>(K4-TI8:' M\#(QHI.'GAZ0H32(*P;QG_J$L0``@`"``'WPM/Z4!G!/L*V20&((K'&0EU," MJ&*/)D,EI*J.$C'^H9V-M1Z!H".-X`AY^GRZ2IP=.G7B$\0``@`"``'UJ ML^FCY6_8KXZA4&&0JSV>S5*&IQN@F\6%*```@`"``'*OQ4ALWF6EP*QMM%@=O#ENGTG3M^QOE3IUM`%P M@2E3L31Q+126L>EPN```JRET>P``@`"``'*BQ'=T<&7#O[%TBU@ZNP1TU4GQ MMH9U0#J6LG9UORF-KW]V(145K\1UNP`/J>EXYP``@`"``'*CPSI[N&6JOG)[ M15@FN;5Z_4G6M21Z]SJ(L0-[$BF>K?)[.!5NK=Y[!`"CI]-]+@``@`"``'*5 MP>V"VF6`O2:!^%?GN&J!0DFHL]*`S#IFKZV`EBF(R%?`MT6'MDEULJB&VCI1KG.&42F>JT>&217M MJJ^&D`&1I%6!#P``@`"``')1O_F1:&5*NQ^/RU>RMDZ.5$EGL:B-(CI!K6R, M7BFHJB&,A18GJ5B+@P'QHNJ!4```@`"``'(POU"8TV4_NF*6X%>NM7^5"DEC ML,^3C3H_K)"2PBFVJ3B3!Q9@J"V/(0)'H;2!B@``@`"``'(3OM.@8&4]N M&E>QM-6;[DEDL!::.CHZJ]*9MBFWJ'V8>1:%ITV/.@*-H+.!N@``@`"``''^ MOG:H-F5#N5"EHE>[M$.C*$EKKW>A:SI%JRF@42G0I\J<11:HIH^/4@*ZG_.! MV```@`"``-FU<8%LJL4.*!U@C9Z>:!VP!(">GEVK=>W;U=WWL-P<-QX1ZY)"%[/A#.>,)ZK=7B;82#'<&D;QN"9ZRU<)F!PI;, M<@"!28`<6`2C1L=KQ_[P_`=T%_(M09:^J.2K_5;8Z, MD*KN;QF*\)4Z<)>)=7ZP<@Z(,6=7* M&`X.=-2&J-$F:8JDG;SK:SBA(Z@";,^=JI)A;ER:47P<;^B7*F4*<6B4/TSC MKBJ;K:_FG*Y%);86BYWL8;QB> MYF0F<)^;,TP9<>B7[S$Z M;-:KF'HO;FJFQF-7;_BB;4MP<4.>R#"J<9>;D`QG()>1KB[=]>F1M2Z/!>N9NZX\">VAP='E5>^YQ^F*U?'QS?TK2?15T[B_A?=!V M'@LY?V1V-\CI=^AV/+97>)%VY**D>2UW@XWL><1X(GA">EUXRF&O>O]Y>DG9 M>Z)Z&B[U?$EZD`IK?;%ZJ,=E=BJ`Y+2N=N:`AZ$<=Y6`+(QS>$-_Z';R>/5_ MN6"%>:U_F$C/>EI_N5_0`FV?#-^UL73=*6+>K,+=6N*,Y]X=B>(\HL# M=N2'Q'6B=ZZ&OU]?>'B%T$?5>2V$[RTP>9R$-`D9>NB"=\1;/S71E=HF-X5Y(=V:,+4;M>""*G2QL>'*)B@B3>5,UU+=G22KD8;=S20BRN]=VN/ M>@@B>-V%@,(K<8^K?J]F55P?$>!>%0,%NQV9KZ:(P=X=W:%#<#P<)3!-JX7<5Z\`YI2<@FVB876 M=(2H"$0[=3NE$"HJ=2.<@@<[=O:$Y+MN@I1JG*HQ@CAL M>)?K@?EN*H1Y@=%OOV_\@;EQ35IP@;ARV4.`@=UT1RD$@H%U4P4\@[MVC;I, M@+UTLZD0@(UUC9:S@&5V5H-/@$MW%V[E@$)WW5EP@%!XID*3@'AY6B@N@/QY MR`3(@@QZTKD\?92(U:9V*=#*/S>UZ: MHY&H>UZ8'GYU>VZ5FVIY>Y63/%6*>\^1'C]&?`F/=25H?`^/``-^?4&"7+1U M>IZG2:,->IVD)I"\>IF@U7V*>J>=B&F@>M2:=53.>Q*7OSZL>SZ5QB3L>RJ4 M(`-)?'V".;/,>@NQH*)8>@RMQH_X>?^IKWS">@2EF6C<>C&AW50:>GF>NCX9 M>J.FJ84@,>>]V"'+-<>:>\(*'2>:>WF(]6>8VROGP4>8.MZ6@Y>:BI MEU.,>>ZF03V7>AJC?"0+>UZ"!*S8B[UIVISYBH!KNXO]B7YM<'G` MB*EO"&9IA_%PF%'LAV)R)#OHAR!SA2&QA_5T3@``AX%W)*OSB@)S99P'B/AT M58KNB`QU,GBYAS]V"&5QAHUVXE$'A@9WO#L1A"#VAFIXQP``A95[%:KP MB&I\VYK5AWM\^8G9AIA]"W>=A=I](61QA31]1E`IA+A]=3I1A')]F2!5A/1] MD```@^9^BJG1AO:&6IFDA@^%MXB0A3Z%`':+A(:$4V-Y@^V#PT]<@WF#23FF M@SB"XQ_&@YB"N```@F^``*BEA<./VYB8A.".BH>#A!>-(G5B@V>+MF)O@M:* M9$YK@G6)2CCA@C*(;A\R@F:(>P``@2Z``*>KA->9?I>6@_J7?H:!@S"57'1O M@H"3,V&,@?&1,$VJ@8:/>#A%@46.4AZU@5B-W0``@""``*;BA!RC,I;(@T6@ MB(6M@G:=K'.9@<*:RF#$@3>8)DT`@,V5\C?'@':4NAY1@&R25P``@`"``*9* M@X^M")8C@KZINH3X@>>F)G+A@2:BC&`2@)>?5DQ3@#F4 M1```@`"``*7C@RVW&I6D@F"S,X1>@7RNZW(\@*FJH%]\@!"F[TO7?Z^D>C;- M?UBA>1V>?PV4!P``@`"``)ZFE1YI3H_4DR9K(W_ND7ELU&[,D`-N:ER-CK!O M]DD/C9UQ=#/6C1!RLAF'CJ)R]@``@Q9ZO)WLDY1R6H\6D.BP%\7S)^BF-\D1A^BWQ\;```@%J``)P9 MD+>$*XS]CPN#LWSVC7Z#-6P)C!""N%GZBM:"6$;.B=.""3'EB3"!S1@1BA*! MV0``@`"``)LFCX2-+(P`C>*,$'OXC%Z*Z6L(BO:)OUDMB;6(LD8'4!>PB,:'6```@`"``)I2CJ"648L_C0:4F'LWBWZ2Q&HUBA20\%A>B-6/ M1D5MA]2-\3#+ARF-31=)AZR,!0``@`"``)FDC>^?@HJ'C%J=,'IYBLV:M6EZ MB5Z8/5>MB"&6"D35AQR46S!>AE>3]!;_AK*/C0``@`"``)D&/80``@`"``)B] MC0BR5HF$BWNN\7E6B=RK.6A.B%*GD%:1AP:DE$/5A@2B]B^&A3B?'19KA4B/ M*```@`"``)#8GN%HS(+7G$QJC7/?F@)L-&/$E^]MQ5*'E@MO23_LE(9PL2M* MD^AQLQ!LEMYQ+P``@`!]T)!`G8UQ8X)(FQ!R47,\F,-S.F,FEJ-T(E'PE+9U M##]EDRIUZ2K3DG5V>A`XE/5U\@``@`"``(^8G"%YV8%UF;IZ$G)]EVUZ36)@ ME5-ZE5$]DVIZZ3[+D>%[0"I9D1Q[<1`&DR][)0``@`"``([/FLR"/8"2F&Z! MVW&$EBV!>6&0E!.!)E![DC>`ZCXJD+.`PBG>C^*`J0_2D9*`J@``@`"``(X` MF;2*J'_&EUF)N7"TE1V(QV"TDP>'WD_6D1R'##V;CZ"&>BEWCL&&/@^MD!:% M>P``@`"``(U5F,:31W\7EGB1RW`!E#R00&`*DA^.ND\SD#.-8#TECI^,:BDB MC;:,70^+CL")D0``@`"``(S&F!B;]WZ:E<^9^&^"DXF7U%]ZD6"5N4Z>CW63 M\3REC>*2S2C/C-B2Q0]IC9V*:P``@`"``(Q5EYFDOWXBE5*B0V\`DP.?DU[V MD,V<\4X=CMR:U#PFC4^9W"AKC#B8&@]+C*R*5P``@`"``(P!ESVMQ'W#E/2J MW&Z1DIJGJ%Z"D%:DD4VTCENB43O/C,:@]2@?BZ^;(0\%CBH'AL_DB+G@YNF^-P6@A8G:]P M(```@`"``(,2I_)P9W7>I-9Q1V>MH>=R+%B!GR=S%D@PG*MS_C9GFL-TRR(K MFD=U'@B`FW1U,0``@`"``(*6II9X:'4_HXAXHFPFU1Y MH#8`F6=Y_B'KF,QZ%0B=F6=ZIP``@`"``((`I4*`4'20HCJ``&9?GTY_ME=. MG(Q_@D<&6UGCR&K5:?FWF%\4:6F/J%7#4;EP^%`B%:ED*%%`B\E=^#T0``@`"``(#8 MHTN07W-HH$Z/&64NG6&-RU85FIB,CT83F!*+B#3(E@>*\2$KE22+8@C,E&"% M\P``@`"``(!MHI"8AW+WGYF6SF2XG*B5`E6=F=J3346FEU&1\C1WE3R16R$5 ME!Z0Z`CBDPZ&`@``@`"``(`4HA2@TW+#GQN>N61^G!><;551F2R:.$50EI68 MIC07E(Z882#&DV^5?PCHD@"&!@``@`"``'_1H;RI7')]GK>F[&0NFZ:D,E3Z MF*VAI44"E@V@+3/9D_R>?""9DMB6"@CCD3N&`@``@`"``':TL\%G?VGUL#AI M"%R`K.5JC$X8J;QL`CZ'IN)M7"T]I.MN:QBYI9=N;`&)HJIP`@``@`"``'9: MLM!O4FG*KRAP'5Q7JZ9P^4WYJ%1QW3YPI5YRO"TZHTES:ACCHZ=S1@'^H#=U M80``@`"``'8,L7QVZ&E@K=AW&UP"JD=W8$V@INMWPSXHH^QX+2T0H<=XA!CN MH>EX5`)>G?EZ6```@`"``'6LL!U^76CIK'U^%EMWJ/-]W4TTI91]PSW'HIE] MQBS0H&I]T1CGH%I]O`*LF_I^KP``@`"``'5$KO2%X6A_JUB%+EL%I\^$ATRW MI&V#\SURH62#CRR0GS*#:QC9GO>#OP+MFCN!^P``@`"``'3DKA.-BF@HJG6, MH&B)FBQ?GAB):!C2G;:)@P,CF+:"'P``@`"``'24 MK665/6?FJ<&3REINIB.20TP8HJV0WCS4GYJ/[BPPG3N0!QC:G)6.60-6EVJ" M0@``@`"``'1=K->=`F>QJ2V;.UHRI8:95DO8H@:7HSR4GNR6M2OKG).6=AB[ MF\:0N0.)EE."9```@`"``'0NK'ZE%V>TJ+ZC&5HNI/R@T$NXH5V>R3Q[GBF= M\ROKF[Z;DQC1FO*0R`.LE8R"?```@`"``&HROP-FM%W.NT!H#E#CMY9I<$,C MM`5JQC0JL.AK]",?KSYLH@XAL4AKXP``GP1SL```@`"``&GMOCUN,EW/NCEN MV%#UMD)OG$-%LG=P;C1;KRYQ,2-SK4IQG`ZUKNAPY@``G! MFB.4J(6!G@^IJ3"!K@``FFR`````@`"``&E.N3R*NUT>M1R)R5!$L0"(W$*> MK0V($#/\J9&'DB.=ISJ'P`_FIZN&N```F9"`````@`"``&DIN'^1_ET4M$>0 MR%`_L!B/@D*4K!N.;#/QJ)N-X2.GIC*.11`BIEF*Z0``F-^`````@`"``&D- MM_.965T7LYZ7YE!$KUF654*2JTV5"#/DI\>4MB.#%SMLM<:>YQ5+A8:^=R9Z1M;;9S=X^? M;V=TAGGC<09UEV,^[ M9>*'4+3":`J&4*$;:@N%8(R::_*$AW<"N''PKD2 MA5ZE;2&0,T>";J:.*2UI;N:,Q0IH<82'"<.V8?VH$[#49$"DEYTJ9E6@^HB[ M:%2=:W.I:E*:$UW(;#.6_T;';;&45"S2;!48D;.J:_2Q/;-F87`FOB/BO&;`"< MJ`EM$)M^UQ:>2QO[D53 M>@]QNRL#>M]S&0>`?19S?;U&%UVY"HX>05WD`;U>UMX%+O`<"YZ:ZH^<7)ZMI?31[[$-S=M9\,BE8=TY\/P9Z>=9\;+HI;EV$RJB:;[*$ M,Y8Q<.R#EH+7!+@8/>(6`,;BN M;-&/*:)A%@:=$2& M>06T=V2#;+=X:Y:9FJ7T;/^7;9./;DV5(X!#;Y&2VFPP<-F0KU!7]);IJ:YFM';^N7 M^59@<2Z55D`^#/;!P M?/]DK*!-?1UG'8\1?51I5WR6?9QK9VC^??%M951$?E9O4SX1?M5Q#R0`?ZMR M)@'W@6=T`:]3>M%NH)\S>R=P$XW?>WIQ:'MU>]5RJ6?S?#ISXU-3?*]U%#TX M?2QV'2-#?-5XD9W@>4UY&8R^>;9YD7I+>B9Z`&;D>IQZ M=E)F>Q]Z[3QP>YU[3"*!:!SWCZ M>):!2>!)E%:>;R`Y3N/>CJ`HR'F>F2`5@%+?=%_NJMF=9>,0)L@=BJ+ M0(GE=K2*)7>Q=S^)`&2<=]>'ZU!F>'V&^SK'>/J&*R%)>.B%S`$@?AB`PZI/ M=&F6,IH)=0.4>(C1=9&2EG:D=B.0J6.A=L&.UD^2=V.--SH9=]^+^2"_=YB+ MM@#]?E6`JZEP=OH?J=*.;%G7!=36896+,==J5XD[;=H"3L3F* M=NN2*"!1=G.0S`#??H>`EZC*:>#C]=BR9$!_O=7J4]`#'?K"`AJA<H.&%S=':D@4VE=2*AL#A\=8.?AA]W=*B51@"T?M&`>:)_A<5D&9.@A19F MB8.7A)QHPG(_A$=JT5^XA`MLRDOQ@_)NK#:!A"!P2!QEA6%PY@``@$QVNJ&8 M@[AM@Y*G@T5O"8*`@NAP;7$U@I]QOE[#@FMS!$L7@EIT.S7`@GUU.!O(@V]U M9@``@`!ZN:"+@=EVU9%F@8AWBX%=@3MX*W`2@0-XP%W`@-YY54HX@-=YY#4% M@/-Z3QLW@9IZ+```@`!^.I]F@!F`)9`S?]V`(H`7?Z>``V\3?WE_WES;?V1_ MPDF`?V9_K31X?WY_E!K*?^%_5P``@`"``)X[?K")?8\D?GV(SW\'?E"'_VWD M?BN''5O6?AZ&2DB1?C*%F3.R?D*%#1HY?EF%#```@`"``)U$?9"2[HXD?661 ME7X*?3J0#VSR?1F.=UKU?0Z,^$?7?1F+L3,8+FPF?#25Y%HT?"Z3R4\>. MV0``@`"``)OE>_NE\XRV>]RC57R.>Z>@:VMW>WF=W&:R4:/>X.8PS(? M>VV7^1D@>L20_0``@`"``)M]>W^OGXPY>V*L;GO\>R&HV6K>>N2E/%C^>M*B M'489>N"@&C&O>L:=GQBX>?*0MP``@`"``)31CPQCDH;RC9UE\7?PC'EH(&>? MBXEJ)U8;BKML%4,]BBIMX2YVBBEO1Q/(C)MO%```@`!Z0)00C2UL>H8KB_=M M_G<.BN5O:&;+B?1PP%59B25R"T*1B)-S/RW?B'UT'A-BBGUSK```@`!]MI,Q MBU]U1X4(.@``@`"``(^HAF*8M8&:A7B7 M%W*%A(F5.6)G@ZF31E%M@O*1BC]5@F600BMO@?N0'1'E@AZ,&0``@`"``(\@ MA;RAOH$)A-F?EG'I@^&=&V',@O2:BU#5@C>86CZY@;*6]"KP@3J61A&R@1&+ M]P``@`"``(Z^A46J]X"7A&6H5W%C@V*E16$_@F*B(5!8@9>?F#Y6@0J>92J; M@(Z;-1%Q@$6+RP``@`"``(=\F)UC%7IIEIAE66Q$E.-G>%SADV1I,R'9RCZB+[V@_C@^*]%D8C(F)ZTD&BRZ( M_3>&%```@`"``(,FD'251'7QCMV3\&>\C3N28EB& MBZB0Q4AKBDV/:#<4B4*.F".>B+*.Q@K&B!V'20``@`"``(*QC]:=SG5VCD*< M!69[U@$BO:7S$?JB9.6&C:/B(R5:R,TA^F4%0JVAQ"'/@``@`"``(): MCV2FA'46CAQU>1BF>?+T>$B/>=4C8\A^6<<"+NASF7G@J5AD:' M*```@`"``'J0HJ5B<&X3H"9DE6"KG>YFH%(@F^=HBD)8FAYJ3C#BF/YKPQR! MF<%L/P/?F*%LO@``@`!_T'G\H4%J>VV@GLQKXF`TG']M05&YFEUNE4(!F(!O MTC"CETIPU!QFE\]Q!P0@EA!QT@``@`"``'EKGZ)R6&SNG4)S(5^=FO1SYE$A MF-%TK$&"EO)U:#!$E;%U_APVE@5U^P12D\5W30``@`"``'C$GA!Z'6PRF[MZ M85[-F7AZG%!\EUAZW$#LE8%['2_3E#Q[3QOWE&=[,01TDF#6!=D_(EA.!+4!HE#2`^"]DDN^`W!NUDO6`V`2.C_V` MG0``@`"``'>&F[J)WVKZF7.).%V3ES"(=4\ZE0F'K3_BDR*'!R\9D;F&L1N/ MD9V'%@2HCG:#)@``@`"``'<1FMV1UVJ`F)Z0Q%T5EEB/ADZZE"N.2#]MDD"- M3B[$D,J,]!N&D&6,I`3'C2F#.P``@`"``':SFD69ZVI+F`:8@US=E:Z6RTYS MDV&5##\>D663UBYCC_N3TALPCXR1/035C!R#10``@`"``'9KF=:B*VH"EXV@ M>UR+E2>>7$XH@-S`3?MG[ES MNB<;GG)T+A*2H!-SF```E:!X,```@`"``&RAJ.IX"&"OI@-X4U/]HRQXG$9J MH'IX[S>)GC-Y02;=G-QY;!*7GC)X]0``E#!\8P``@`"``&PHIY!_;&`XI*]_ M4%.!H=E_*T7CGR9_!#&\E_9HZ6&=U,EH,>%Y$6%G@N%4#;8FZN$Y29OFBB$U1*2FP.$N```D<:` M````@`"``&MDI;>.?5^1HM*-KU+?G^>,LD4ZG1Z+NS:&FKR+&R8[F26+2A*E MF:B)H0``D-N`````@`"``&LDI0^6$%]4HB:4]5*`````@`"``&KPI*&=XU]6H:28SR7\EVJ6YQ*JEZF,G@`+CXJ`"```@`"``&&SN'Q@B57TM7QB M4DFALI!D&#QAK\-EPRV[K8QG)1R2K41GN`A.`````@`"``%_] ML/R+%%2UK8V*?4B8JA^)O#N+IN&)""U=I#&(MATKHMZ)(`IEHDJ&B```C3.` M````@`"``%_9L%>21E2RK,N1?DB8J4B0=CN%I?F/B2U+HT&/91T8H>R.O`I\ MH1^'%P``C)R`````@`"``%_!K]V9H%2[K"R8O4BCJ)&7@3N'I326A"U2HFV6 M+1TSH0&33@J2H"*')@``C`"`````@`"``,$39Q5?[:[3:3EBM)OM:SYE8(@B M;21G[G-I;OAJ:5VW<+ELT4;')W)6R8J:(M8)I90R'EVY29V*& MCEDU:9"%IT+G:SF$S2F):QF$&@@4,'4(::>.*H"CE:7Z)L0?!/R@=\'R=N9PEQ$K'";"QIJZ%[;<]KC)``;U!M4'UK M<+UN_VG#`/A>7)UR;`Q:;5S])_-:WYT MWXY[;2!UN'OV;JUVC&AZ<#!W8%/M<:%X+CW^>MZ1JZ2 M9X)^'YXF:69^+8S::R%^+GJ5;,=^*6E-^*ZT099^(1YRS9YB'BXML:6F&NGDN:R"%X683;-&%%5'7;FR$9SQ+ M;Y*#QR,P;P:#4P,F>JV!@JO69!B2?9N`9A^0_(I!9_J/67@.:;^-KV4%:WJ, M&E#V;1:*KSN4;CJ)B"*@;5V)'P+Z>OF"`ZK<8MRS>!ZJHC8>RF[9G,8_ZC MZ8B$9=F@J'969Y^=8F-@:6J:84^`:Q27T3IN;"&6%B'):JJ3D`*W>VJ!UJFM M846Q'YE&8U2M6X?H92*I376Q9MRE16+%:**AI$[Z:DJ>MCGK:TJ<^B%/:8J6 MA0*?>Y.!Q:6D=Q5>PY9Z=Z]ANH8T>%QD='2G>11F^V'P>=-I9TX&>IMKMSB+ M>V9MOQ[+?#MNTP``@`!R8*1X='EHC95:=51JCH4!=B5L:7.+=O9N)V#N=\MO MU4TB>*-Q;#?#>69RQQXH>=AS40``@`!W!:,V!V4TQ&=L=W-C<1=X5W[1V==Y)X!P``@`![&*'$;_5[]Y*-<1=\ M3X)8^./G_X;Q.,]V[-<"R+G5R]<46*54F-Z5/VWP;PN3)UON<"Z1 M-$C<<3>/B#19<<6.<1N0<%V-6```@`"``)W$:I:BTXZ*:^.@5WY8;06=D6TU M;AV:O%LV;T*8*T@P<%*6&3/1<-25'QLZ;S61>@``@`"``)U4:?&LEXX(:SVI MU;XJ=`S-6;_^;>!K$;D>2&0``@`"``)A0 M?Y=>6HI)?W!A1GL8?WAC^&J6?YYF=EC8?]=HU47&@"YK#3#E@+YLWA:U@CUM M-```@`!V7)=3?1MGF(E&?3EII'H!?61KAVF1?9QM35?M?>-N_D3[?D%PCS`Y M?KUQR18V?[-QNP``@`!Z9Y8Y>M=POH@!>R!R`7CE>V)S)VAX>[!T-U;Z?`AU M.D0O?'!V*2^7?-MVV!7%?4AVA0``@`!]\Y4%>,1YYX:\>2IZ7>85ZVV=Y M>>%[.580>DY[CD-Q>L![W"\)>QM\"A5F>QU[I@``@`"``)/3=P>##H6N=W^" M\W:$=^J"L&9->%*"4E4?>,>!^T*6>4B!M"Y7>9*!=A3I>4V!4P``@`"``)+4 M=:2,2X2I=B:+AW6$=I>*D658=P:)@U0Z=WZ(@T'@=_:'KBW&>#"'+12!=\:& MI@``@`"``)('=(*5B8/;=0R4(W2W=7V2?&21=>Z0P5-]=FR/*4%!=N*-X2U: M=OR-4Q0Y=GZ+%@``@`"``)%JS(,W=#"&/G=0B8$U+7=8:5 M\T"A=@"49BS:=@>3_A/U=7>-?@``@`"``)#]A`=O4WP=@Z1PHVWM@T)QVUYW@O-R^DW?@KMT"SO8@K%T^B>S M@O=UAPV>@^=T[P``@`"``(A/@A1WZ'KZ@<5XEVRX@7AY*EV$@3)YJ$T`@0UZ M'CLC@0=Z@2)3WDV?MB( MTVL"?IN((UO"?EZ'5DN-?C>&ESG]?BR&"291?B2%V0T-?GJ$HP``@`"``(6Q M??.2$7AY?77UIY?&^58DI)?$:3LCC3?#22L26" M>^:22@S+?">(I@``@`"``(2X?'^CL7=T?&"AK&DO?!.?.%GV>[RX>: MK#AV>VN9X"4F>PR7(PR*>U^(>@``@`"``'Y#D?E=9G':D)%@&F1ICW%BIE6Z MCH-E!T6^C<-G.30?C7)I&Q_2CE9J%P9.CIEJ%```@`!\RWU[C^AEJ'$JCK!G MH&.RC9EI?U49C*1K0T4VB]QLY3.UBWUN11^.C"=NX`9JB_9N\```@`!_WGRN MC==MT7`ZC,5O(V+DB[QP8E1.BM!QCD2+B@URHS,NB:ESAA\VBB-SS`9WB9]T M*P``@`"``'O)B^UUZ6]$BNYVJF'>B?EW5%.%B1-W\4/7B%UX>S*CA_9XYQ[= MB$9X[09\AY)YOP``@`"``'KIBDI^!6YXB5A^1&$9B&M^9%*PAXY^:D-1ALM^ M;3(VAF=^=QZ=AHQ^8P:,A<9^KP``@`"``'HBB/J&1&VYB!:%^V!>ARJ%AU(+ MAD*$^$*ZA7R$<3'RA/>$(!YNA/F$.P:1A#R"VP``@`"``'F#A_2.C&TZAQJ- MSE_CAB>,RE%WA3"+IT(9A&F*LC%@@]Z*,AXI@Z.*B0:+@O.$;```@`"``'D$ MARJ6W6RYAE25L5]=A5F4)U#UA%62?$&:@X.1,3#4@OB0R!VX@IN/U@:)@>6$ M:P``@`"``'BBAI*?36Q2A;Z=RU[JA+B;QE""@Z69HD$V@L*8)3"&@B:7MAV! M@:^3\P9]@12$8P``@`"``'&OF]AD-EVK0"BC&MY M1```@`"``&[7E)M[D&,7DPQ[XE9QD8)\'4C0D`E\0SH2CL]\9REUCC%\?!6< MCPY\.@##BJI]I@``@`"``&XRDUN#6F)\D=:#/E7`EP``@`"``&VLDD^+)V'UD-6*H554CT6)Y$>S MC;^)%3D&C':(=BC/BYV(415UB^.(!`$#A]^`KP``@`"``&U"D8N3"F&QD!>2 M-542CGF1`4=IC-./L3B\BW2.TRAPBIZ/!!49BL>,H`$:AM&`O@``@`"``&SO MD/B;#F%?CWV9^%2YC=287T<0C""6L3ARBK&5T2@YB<65)Q3\B%4WPHB-@94"KH%MBC3'RGP5D:"#GGQ-EB@O[ MH;ME&@``C91MT@``@`"``&2SI,QC)UFFHHYD\4V3H&UFL$!LGGMH5C'2G/]I MOR#SG-5JB@Q/GOII_0``B_MRS```@`"``&0KHNAJ=5D,H+AKN$T9GI1L\3_X MG)IN'C%_FQ%O&B#0FL%OE0Q]G&QO!@``BGMWH@``@`"``&.=H0=QJUAKGN)R M>DQHG,ES/#]UFM%S]3$1F4ATC2"0F-YTPPR.FAET50``B11[Y0``@`"``&,. MGVYX\%?AG5-Y6$O>FSMYK3[CF3]Y[#"TEZEZ)R!-ERUZ,0R.F`%Z*@``A]%_ MG```@`"``&*0GBR`5E=QG!:`84MUF?B`2#Y\E_.`&C!5EDY_^B`EE:)_^`R5 MEAZ`$0``AK2`````@`"``&(FG2V'OU<9FQB'>4LDF/"&^#XHEMR&9B_ZE3*& M#A_FE&V&1`RLE'2%#0``A@``A2&`````@`"``&&5F\N6S5:_F:Z6 M)$K%EVR4[SV]E2B3K"^KDTJ39Q^QDEN1[PR_D>R(GP``A)R`````@`"``%DC ML:U:9$X:KU)JC6-B(Q63JV%B:`-%J;9C6@``B.=Q M_0``@`"``%APL&=A?4VZK>)C&T(CJVIDN35_J2YF.B```AF=ZW0``@`"``%>NK*=O.DS?JB9O_4%7IZAPN33G MI55Q;2;?H[QQ[!8*I$YQJP2$H5QR_```A4%^B@``@`"``%=2JOUV'$R*J()V MBD$$I?]VZC2*HZ9W,R:ZH?5W;18)HEUW*03"GP9XX0``A#Z`````@`"``%;_ MJ:U](TQ0IRI]2D#5I)U]3C1>HC=]/R:2H'1],Q8;H)=]%@3_G.]^%@``@UZ` M````@`"``%:ZJ*"$+4PIIA*$%D"YHW6#QS1!H0*#;"9TGS2#1Q8=GRV#AP4^ MFR&">@``@JV`````@`"``%:%I]*+0TP3I3**_4"JHH.*9S0RG_Z)SR9=GB&) MRA7_GA&)-@5-F:N#E@``@A:`````@`"``%9BIS22?DP,I'J2(D"GH;J1530N MGR.0I"9GG2^0F18FG/:-Y`5JF'"#J0``@8"`````@`"``+4F85-9LJ/^8]%= M`Y(V9B]@-W^&:'%C3&O>:I]F1E:D!O+D`U:_QQ!B<8;!)R M7@9C=35S0;%.6K%O`:"J7;-P2H]-8(-QC'S68R9RSFEN9:QT#53[9_YU0S\^ M:;MV5B91:65W"@87=;5X(J]T5^5Y@9[=6Q9YW(V,7@EZ.7M98-)ZEV@48W][ M`5/49>I[:SY.9ZA[Q"679MU[ZP75=B1\FJV^57B#\IU&6,Z#=8P$6^."]GG> M7L6">6;B88R""%+(9!&!KSUV95!N@0XD*5UJ=-W<,6F2:.V0W7527@%!X7_&5'CN< M88J35B..7VR1[`4F=TR#>ZG!3YBM=9F24S2IH(AX5FREN79Y67"A^&.P7%Z> MF5`$7OJ;Q3LH8'^:!2,B7D66'@4-=W>#:J@7:-M929AC:JE M8HAMCI5_9-EO#H4W9OMP>'.X:/]QU&$X:N]S)DV6;+AT:3B!;?UU?!^=;2YU M^0$4?BUX9:,T7]=WB)/58E!X,(.69)1XQW)?9KAY45_^:,UYW$R,:JIZ8S>K M:^9ZSQ[Z:IUZX0#]?E1\9J&H77^!?9)@8!F!78(M8GR!)G#^9+B`XE[H9N&` MI$N7:-2`=S;H:@.`2QYK:'2`'0#J?G5_U*!C6Y"+>Y$K7D**EH$)8+B)DF_I M8PF(@UWF94"'@DK)9S6&HS9#:%B%^!WN9JN%V@#9?I&`DY]?6?F5=)`R7+R3 MS(`:7SZ1^V\&89N0)%T18^*.;TH39=R,\S6_9N6+X1V/93.+C`#,?JB`BIZ= M6+N?88]S6XB<]W]97@V:6VY*8&R7OUQ:8KB584EH9+F3:34W9;*2-QTZ9`20 M-@#!?KJ`@IX=5]BI-H[J6J6F#'[#72.BIVVR7WN?3EO08<2<6$CU8\*:!S3# M9**8Y1S+8PV3>`"X?LF`?)LV<+)8]XS5<=\UK6@``@`!R'9GA;8=BC8NC;NYE#WPQ<$%G:6NC M<8QIH5GE^;FQXHT46;\)Y03#'<(EYMQ?*;^QY MC```@`!^<96@9<9_#H=G9Z9_/'@S:5Y_1F?X:OE_.5;&;(A_+$0Y;>U_*#`: M;IY_'A=2;@9^\```@`"``)1[8^J(DH9,9=^("G$OQ;I;'*$P```@`"``)./8F*2$H5E9&:0V'9&9C:/9F8A M9^V-XE4-:9*,?4+6:O2+5B\5:VJ*K!:=:R.)QP``@`"``)+>82Z;B82R8SN9 MH76.90Z7=65N9L.5.E1>:&V3/4(O:=*1LBZ3:BZ1)196:A6-Y0``@`"``))F M8$VD\X0N8EVB9W3[9"F?A&399=:.=8L8$G>5)<"7*W>>%?*&+^>H1B$U(!>S%DU#^=>^]G7BL\ M?,5I6Q#>?E!I8```@`!V"8U2=>%ANH`0=IED0'&<=U)FFV']>`]HTU$?>,]J MZS[=>95LTRJ?>D=N0!"(>X5M]@``@`!Z'XP=7![=.-N'6#E M=;MOHE`R=H]Q$CX:=UUR72H+=^US11`]>1!RRP``@`!]M8K5<)-SLGUK<:AT MP&\IDY=.%>FT.;O^%#%W'<`F$@DU_<0>#_SOC<=N#F2A; MR:RR.NGIU;'F-WFQ!;9R,PUT";JN+D4S&;["* M>SM(<'Z)IB?Z<'"):0\N`;R>/[`\`<5"*)0``@`"``(:7:22@LWE/:G^> MM&L*:YZ<45O0;*&9WDNG;9V7TCI%;E^6KB<5;@F590ZG<)&)Z```@`"``('7 M@8M87758@5A;EV?&@5I>H5CL@7UA=TC!@;AD&S<#@B=F<2+1@QUG^`CGA*1G MWP``@`!YELF@``@`!]!G^Z?`UI77,Y?%9K*67-?)=LV%<9?-QN9D:9QRG(.>@UR]V26>FAT!58N M>KMT]T9;>R!UTS47>X=VB"%T>]1VT`BR?7!W"P``@`"``'V`=XEZ2W#Y>`MZ MW&.,>'E[254L>-I[F46T>3][X32+>:E\&R$9>Z%\E@``@`"``'R/ M==>"WG`L=FN"WV+-=N&"K51?=T:"7$3E=ZR"$#/R>`*!WR"?=^.!U0B#>A^! M7```@`"``'O+='&+:F]F=1"*WF(,=8F*$%.E=?&)*$0T=EB(73-<=J"'V2!* M=CN(#PAR>-B%50``@`"``'LQ:_6#SLA3YILUL+A.EK9DTCA*%L^3WXA'AN9"T'A*%O?1D` MA9EOH`).A1-Q-@``@`"``')P@S]OWV:A@PAQ&5GV@L=R.$Q*@HQS/CTT@G!T M(RQM@HYTRAB<@S9TL@)=@PIVS0``@`"``'%]@4)WX&6Y@1UXD5D.@.IY(DM= M@+=YF#R9@)-Y_"OH@*EZ0AA(@/]Z$P)N@41[P```@`"``'"F?Y!_\F3O?W^` M(UA2?U6`)TJU?R&`##P'?OA_\"NS?NE_Y1@S?O-_Z`*-?[U_^```@`"``&_V M?CF("V1A?CJ'QE?/?@V'/4HK?0 M>[2+6P*??6J!Q@``@`"``&[]?%.82V-J?&"70E;3?"R5OTD[>]:4(CJ7>XV3 M$BI;>TF2_Q=1>G6/CP*0?*"!O```@`"``&D#E']7"EW0DTA9]U&NDE5J%T?D11@ M_5$)D"%C.$/,CU%E3C47CLQG'R0^CQQH6P]ID6UG^@``AB)N9```@`"``&=1 MC[9F-UQ`CLQG_5!0C>=IK4,CH)LZ0``A%YS MIP``@`"``&9^C7%MO%M>C)YN_T]BB\EP*D)EBP5Q/#/LBH!R("-OBIARG0\W MB\]R#@``@KQXF@``@`"``&6OBWUU3%J6BKQV%4Z;B?%VPD&>B2YW4#-FB)]W MR",#B*)W_0\,B5-WE```@4Y\Y0``@`"``&3WB>)\\%GNB3!]2TX`B&=]>T$) MAY]]C3+>AP1]F2+9ALQ]HP\+_]L`0P`%!`0%!`,%!00%!@8%!@@."0@'!P@1 M#`T*#A01%103$1,3%A@?&Q87'A<3$QLE'!X@(2,C(Q4:)BDF(BD?(B,B_]L` M0P$&!@8(!P@0"0D0(A83%B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B M(B(B(B(B(B(B(B(B(B(B(B(B(B(B_\``$0@`30"?`P$B``(1`0,1`?_$`!\` M``$%`0$!`0$!```````````!`@,$!08'"`D*"__$`+40``(!`P,"!`,%!00$ M```!?0$"`P`$$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?( MR;GZ.GJ\?+S]/7V]_CY^O_$`!\!``,!`0$!`0$! M`0$````````!`@,$!08'"`D*"__$`+41``(!`@0$`P0'!00$``$"=P`!`@,1 M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6& MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76 MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:``P#`0`"$0,1`#\`^R**X7Q1JMYH M/Q`\-7+W3KH]\);2>(GY!)MWHWU^4C\:\_T?QWK6GZ?XFOM6O)9O[0L'U'28 MG_Y9@RM&J+^<9_&MXT)2C=&4JRB[,]ZHKQK_`(6F_AJ`Z;>B*]DT:.*+49[B M[5)Y9"`6,:8^?&>>E>A>(?$ZZ'IFG7X@,UI=7,4,C[L>4LAP'_,C\ZF5&<6E MW&JL6O0Z.BO-W^*<"2^(D:P6UB M89)8HI$2^!N%+X&?+QT!/_%?4=+ELK8:1#:Q2H1-\RJQ;#XV\D MX'&>*/8SM=_U_5P]K&]CT6BN2U?QI%HGB&[L-0@,<,6G-?13[N)`IPRX]1Q^ M=8T?Q`U>_D:#1O#XN+JULX[J^26Y\L1>8NY8U.#N?`/H*2I3:O8;J16AZ-17 M&:#X]M_$.IV<%G;NL5WIOVY7H-7M"\1S^(O!IU:QLU%PQE6.!Y, M`E&*C+8XSCTI.G*.Z&IQ>QTM%>3:!\0];C\%6][K>G1W&H7U\UG8QPS#]\_F M,,-P`H4+UYSBNO\`#?BFYU36M1T?6+`6.JV")*Z1R^9')&^=K*V`>H(.152H MRC>_0F-2,K'545Y)9>,9['XJ>)]$M8Y=0U&XNX3;VS282&(1+O(A::"+BQ\.LOVVX:YVEE*!CL7')`)X.*;H3O9"56-KGI-%^ M/;Z;4[VW\-:.-033K>.>[DDG$6-Z[PB#!W-MYYP/>JJ_%6VDL+VZCL9"JZ=% M?6:%L-<>82H3'9@X"]^M+V,^P_:Q[GH[NL:%G(55&23VK/T_7=,U:21-.O8; MAXOO*C9(]_I7*V'B^/Q8FFZ9%:O&VJV,LUR=_-MM.PJ?4[LC\*M>&/!CZ%JL M]W-<)(75@%C!&2Q!).?H.!P*3ARI\VC&I7^'8O>-?"5OXT\-/I=S<2VI,BR1 MW$(&^-E.Q4];'+W7@)_^$DO=3TG6);!=0=9+ MN#[.DJNP`&Y2PRI(`!KH=?T*#Q#X:O-)N79(KF+9YB#E#V8>X(!J9;QK?4AJ]]\*H[O4;^1-:N8;.^OUOY;984),H8-C>1G;D=*[@:FH. M)(G%7U.Y01WKIH9A&O?V<[V,Y8=+='(R^!+:70_$NG&\F":_<-/*X49C)"C` M]?NU.GA)K?QG'KEGJ4L):V2VN;;RU99E3.TYZJ>3TKJ**V]I+N+DB>:_$#P_ M/XL\2^'K""RN1%;S^;=7HP(A#@[HR>Y8A>*V-5\#R7.M76HZ-K-SI,U]"L%V ML,:N)54$*1N^ZP!(S79457M9))+H'LU=M]3@I/AM#;-ICZ!JMSI9$3DYW?Q9YS70>%/#<7A3PQ;Z1;W$MQ'"6(EE`W-N8LO:MOP[X5.BZG?ZG?:A M-J.J7RHDMQ*BH`BYVJJC@#DUTM%-U9M6;!0BM4CA-0^&MG>Z[?ZQ#?W%KJMQ M*+:6]E)\1#]\X0?N_W83Y?RSS76T4> MUGW#V<>QPEU\/&%U--H^N7>FF[MH[:\$4:.)E1=H89^ZV.,BG77PSTJ:Y\,O M!+-!%X?4)'$N")E!!`?_`($H;ZUW-%'MI]P]G'L\+^--#\5P/_`&-=`SP\36LB[)83Z,AY%=)7@OQP\.3^'/L_ MQ"\)M]CU:PE47ACX$\9/\0[\X'T-:T:=.K/E:M)]?\S*I*5-(;+1O+CE+2WGN>*^?+WQ/= M2W^D>+[;4HY;C4V\ZSTNWB/FLQ4)MD<_P*0<`=:]H\$>%Y].MVU;7Y/M7B"^ M&Z>9N?+':-?0#VK66#C1C[2?7IU;_P`EW,5BG5G[.GTW?9?Y^1T6E2W]S;O) MJMM#;LS?)$C;BJ_[1Z9^E:7045SGCC6GT#P1J=];C-RL6RW4=6D;Y4'YD5S* M/-*R6YU7Y8Z]##\"_$>V\9^(_$NF1+&C:1=>7$5.?,CZ;O\`OH']*[^OA3X+ M>(KCPA\:K:#4F:-;R5K.[#'HQS@G_@6*^ZQR*ZL=AU0J6CLT<^$KNM"[W044 M45QG4%%%>=W/C+[1\=--\,6-SF*"PFFO(UQ@N=NP'W`R?QJX0<[VZ:DRDHVN M>B4445!04444`%%%%`!1110`5Q_Q-AM)_AIK4>HB0VIARZQCYFPO"/=HPQ4_9T)R[)G@WP[U13\0M)O+ MQ((%>811EU!"KC"HBG[H'3-?7@Z5\7S^&K[PMI7A;Q-,,QW4@?RVS\I5LC\" M,5]DV M.O#6@K\T4+MJ5T/18^(P?JY_\=KN^@KR?2)O$NI>-O$>O:!9Z7"Y;\J\BDMWV/9J/9'SK\?_#DGA3XO27]F"D&HA;N)@.CYPP_, M9_&OKKX?^(T\5_#[1]71@7GMU\T`_=<###\P:\3^/_AWQ3KG@9-5U?3=(B32 M'\QI+.Y=Y-C$*1@H.,X/6JO[,/B[_B1:YX?GD)>T4W=NI_NGA@/QQ^=>G67M M\'&76.AP4G[+%./21V/C;XG7U_\`$VP\`>#9TAO+B3;>7^`QA`!9E4=,A1UK M6\6^$]6\.>$K[6?#GB;5SJ>GPM.5NY_-CGVC)#*1@9&>F*^8_A?J.K:C\?K2 M_P!.2WGU.XGN)%6[=E0DH^#/&DGQC\*2;-:O-#U:P0B[@L" MH$@(X<;@2!7B'P8TV\UKXVW42ZQ?6MTJ3L;R(AI&P<'.X$'->I_"KX*^*?AY MXOEU34+_`$Z2PDM9(IHK>1RS9&5X*@<$"N`_9[_Y+[>_]-M#"7/*5+VBL[GU"WA;4_['%J/%.J"=93)]JV1;R,8V_=QCOTKY;\+_%[ MQ:/BE!;:IJ5YJ-O#<20QV<:@&=^513@=SBOL]ONGZ5\-?"=%/[2=LI4$"^N, M`^VZN;`\LZ=5S5[(WQ=XSI\KM=GT\O@G7M?M_MGB7Q/J5G=RCIKRWX>_%/7-$^,%WX'\47S:E:F[>UM[J4?O%8$[6[D M3>+>(G&X+W/!_*NDL?`AU#0X+Q/%VOSW%S")4O$NMJG<,A@@&,<]*Q?C!X'\ M#:Q-9ZYXVU-]->W3RPZ2`&50<[<8)/4]/6MG1/']I-HMK#X3\-:]?:;;Q+%! M,ENL:%%&!@NP)&!Z5B[>QC[):]7_`,$T5_:RYWIT.#^&/Q>U:Y\?WG@CQ2\= MU=Q2RQ6M\%VEV3/#@<<@=:[?PK'XE7Q/(=1-X8V!\T3*0BG!Z$C!YQC;GBOF MWP',]Q^U5!-)"\#R:E.S128W(<-P<<9K[?K3'0C1FE%?$D3A)RJ1?,]F%>._ M&^22_'AC0+<%GU#4%9E'<#C_`-F_2O8JPKSPS97_`(MLM:NPTEQ8Q,D"'[JD MGEOKVKFPE6-&JJDNE_OMH:8NE*M2=./6WW7U,OX@>'H]8^&NIZ=#$NZ.WW0` M#[I3!&/RQ2_#/5?[8^&NC7#',B0^3)[,AV_TKKV4,A5AD$8(K!\*^&K;POID M]G922/#)][K]?T!T6L0JD=K6?Z?J+XQUG^P/!FI MZ@/]9%"1$/[SGY5'YD4>#M(_L+P9I5@W^MB@4RG^\YY8_BQ-'](O\`2O-74-!77@:].G&<:CT9S8NC.I*,H+5'E?@WP_)X&_ M:KL+&_!C@:XE-M(W`D1XWV$'\,F,(^7SO[-C\['^]NQGWQ4XFHL2U*^J5GO M]Y5"#H)JVC=SHM5U^ZN/&]KH>DLC1PV\EQJ+;<[%*D(F>Q+<_05\Q_L^C;\? M[T-P?*N1@_[U?6'AOPQ8^'+&2*S\R6:=C)<7,[;Y9W[LS?Y`KR[6_@[:Z3XY M/BKPCK%QHNH2NS.B0K+&2WWL`D<'/2GAZU.,9T^ZW%6I3-,T3Q!'K&F>(M5AU&-S(LP6,G<>IP M1CO3PU6E2A.+>ZL*O3J590DEL[GN7:OANY_Y.V/_`&,(_P#1@K['FTJ^D\-+ M8IK5U'>#`.H+&AD.#S\I&WGITKREOV=],;Q-_;K>(M6.J_:/M/VC"9\S.=W3 M'6IP5:G1Y^9[JQ6*ISJU58PJ11I@`<``"O$O&WP)TSQ'Y>J3ZO>1ZVG^MOA&N9L'@LHP M,@8&1Z5MZ)X,UO4-.CL/$'C+4;[3HU"-!'`D#2K_`'6<98C\:K$SI5J<.5VY M5:W^1-"%2E.7,KW/GGP3/%/^U?%-#(KQ/JDY5U.000_2OMI98VE:-74R(`64 M'D9Z9KQ7Q/\``S2)?%EKX@\.:A<:%?0LI`MHU9`5&`0#T.*],\+^&8/#UM.Y HN;B]O[Q@]U>W+9>5@..G``[`<"IQE6G6491>RM8K"TYTN:,EUN?_V3\_ ` end
-----END PRIVACY-ENHANCED MESSAGE-----